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Apoptosis, a form of programmed cell death, plays an important role in the development 
of multicellular organism and the maintenance of homeostasis in adults. Understanding 
and exploring the process of apoptosis will allow us to gain insights into the 
fundamentals of cell death and also provide an alternative therapeutic approach to 
pathological conditions such as cancer treatment and neurodegenerative disorders. 
 
Three decades of research have revealed the mechanism by which the death signal is 
transduced in the doom cell. Apoptosis can be activated generally via either the extrinsic 
or the intrinsic pathway. In the former, death signal is transduced from the ligation of 
death ligands onto the death receptors, which in turn recruit others cytoplasmic proteins 
to form the large death complex at the peripheral membrane. The intrinsic pathway is 
activated when the pro-apoptotic proteins, in response to intracellular stress, translocate 
to the mitochondria outer membrane. Both pathways result in the activation of caspases. 
Activation of caspases, the cysteine proteases, resulted in the distinctive morphological 
changes associated with apoptosis. The enzyme cascade forms the main disintegration 
force that halts the cellular repair system, the transcription and translation system, cell 
division and dismantles the cellular remains into apoptotic bodies. Therefore, regulation 








Using an in vitro assay, we discovered that in the presence of calcium, procaspase –7, -8 
and –9 are cleaved. Further screening using protease inhibitors identified the source of 
proteolysis. Calpain, a calcium-activated cysteine protease, cleaves caspases upon 
activation. Both endogenous and recombinant calpain II cleaves procaspase –7 and -9.  
 
Procaspase-7 proteolytic fragments appeared non-functional based on the sizes compared 
to the apoptotic P20 and P10 fragments. Procaspse-8 and –9 were cleaved into 3 and 4 
fragments respectively. Edman sequencing of the caspase-9 fragments revealed 2 
cleavage sites. In vitro studies showed cleaved caspase-9 was inactive upon calpain 
processing and could not be activated by dATP/cyt c/Apaf-1 pathway, the death signal 
transduction utilised by the intrinsic apoptotic pathway. In addition, pulsing cells with 
periodical calcium promoted caspase-7 and –9 proteolysis and destruction consistent with 
protection from H7-induced apoptosis. This work is the first of two to demonstrate the 
direct cross talk between the two families of cysteine proteases and the proteolysis of 
caspases by calpain. 
 
In the regulation of apoptosis, mitochondria play an important role. The organelles 
sequester apoptogenic factors such as cytochrome c that is required for activation of 
caspase-9. The release of the apoptogenic factor is dependent on the integration of the 
pro- and anti-apoptotic signals at the surface of mitochondria. Utilising mitochondria 
proteomic, we compared the healthy and apoptotic mitochondrial proteomes, to screen 
for protein(s) that might play a role in the transducing apoptotic signal to the organelle.  
 




In this work, we identified cofilin, the actin depolymerising factor, translocating from 
cytoplasm to the outer membrane of the mitochondria at the very early stage of apoptosis 
induced by staurosporine. Cofilin is regulated by LIM kinase via phosphorylation on the 
serine 3 residue upon activation by upstream Rho small GTPase family members. Our 
data indicate that only dephosphorylated cofilin undergoes mitochondrial translocation 
during apoptosis. Further protein dissection demonstrated a hypothetical intra-molecular 
regulation that served to conceal the mitochondrial-targeting signal in non-apoptotic 
condition. 
 
Interestingly, dephosphorylated cofilin translocation to the mitochondria only occurred 
during apoptosis. No mitochondrial translocation was observed in other cytoskeletal 
reorganisation processes such as chemotaxis. The migration of cofilin was independent of 
caspase activation as well as its actin-binding capacity. Using over-expression system, 
cofilin localised on the organelle induced massive caspase-dependent cell death. The pro-
apoptotic effect required the actin-binding property. Although, we had shown domains 
required for cofilin translocation and apoptosis induction, the direct mechanism of cell 
death induction is not clear. As actin-binding ability appeared important for the death 
effect, we postulate that cofilin induced cell death is actin-dependent. The change of 
cytoskeletal network around the organelle may serve to comprise the integrity of the 
mitochondria and aid in the release of apoptogenic factors from the organelle. 
Alternatively, cofilin may play a novel role in death induction when translocated to the 
mitochondria. 
 




Previous studies have linked cytoskeletal proteins to apoptosis. It is often correlating to 
the change in cell shape during the death process. Our work is the first to demonstrate the 
death-inducing capability of cofilin by its direct effect on mitochondria, the central 
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Chapter 1: Introduction I 
 
1.1. Apoptosis- history 
In all biological systems, cell dies during development, for the maintenance of 
homeostasis, to fight infection, or for the conservation of energy. Generally, there are two 
main forms of cell death, necrosis and apoptosis (Trump et al., 1997). Cells dying of 
necrosis undergo swelling and complete collapse as they undergo lysis. The spillage of 
intracellular material often evokes an immune response, resulting in the loss of healthy 
by-stander cells that are being removed by the immune cells. In contrast to necrosis, 
apoptosis is a phenomenon first described in 1972 by Kerr et al. (Kerr et al., 1972). It is a 
distinctive form of cell death defined by its unique morphological and biochemical 
changes.  
 
In the early stages, apoptotic cells round up and undergo shrinkage. The chromatin in the 
nucleus condenses and is fragmentated internucleosomally by endonucleases, forming the 
distinctive DNA ladder when subjected to agarose gel electrophoresis. On the surfaces, 
plasma membrane blebbing is observed, and phosphatidylserine is exposed to the 
extracellular surface of the membrane serving as “eat me” signal to phagocytic cells 
(Daleke and Lyles, 2000; Lawen, 2003). These physical changes are mostly the results of 
the activation of cysteine proteases known as caspases. Before the enzymatic activation, 
mitochondria permeability is compromised and proteins such as cytochrome c (Liu et al., 
1996), apoptosis inducing factor (AIF) (Susin et al., 1999), and Smac/Diablo (Du et al., 




cytoplasm and activate caspase-mediated cell death.  At the last stage of apoptosis, 
membrane bound vesicles commonly known as apoptotic bodies, containing the 
cytoplasmic material as well as chromatin fragments, bud off from the main cell body. 
The apoptotic bodies are taken up by the neighbouring cells without evoking an immune 
response (Lawen, 2003). Due to this property, apoptosis have been intensively studied to 
explore the potential killing of tumorgenic cells by this process, replacing the current 
cancer treatment of radiotherapy and chemotherapy which often resulted in the loss of 
healthy active-dividing cells.  
 
Understanding apoptosis provides an insight into some of the pathological conditions that 
arise due to abnormal high apoptosis, such as neurodegenerative disorders where neurons 
died prematurely in Alzheimer’s or Parkinson’s diseases, or reduced apoptosis where 
cancer and some autoimmune diseases arise (Lawen, 2003). The importance of apoptosis 
is also illustrated in the developmental process where sculpturing is required for 
multicellular organisms as well as in maintenance of homeostasis (Jacobson et al., 1997). 
Without apoptosis, an eighty year old man will have two tons of bone marrow and lymph 
nodes (Melino, 2001). 
 
1.2. C.elegans, conservation of pathway 
Researchers working on apoptosis have made tremendous progress in the last decade. 
Studies on the C.elegans have shed light on the molecular machinery of the apoptotic 
process. During C.elegans development, 131 out of 1090 cells die at specific time and 




demonstrated that the regulation of this timed apoptosis is achieved by 3 genes, namely 
Cell death gene 9 (ced-9), 4 (ced-4) and 3 (ced-3) (Horvitz, 2001). Gain-of-function of 
ced-9 gene in C.elegans prevented the death of the 131 cells, suggesting a protective role 
of the protein (Hengartner et al., 1992). On the contrary, loss-of-function of ced-4 and 
ced-3 resulted in the living of the 131 doomed cells, indicating an opposing role of these 
two proteins with Ced-9 function (Ellis and Horvitz, 1986). More recently, an upstream 
regulator was identified in this apoptotic model. In 1998, Condradt & Horvitz discovered 
that mutation of egl-1 gene in C.elegans confers somatic cells resistant to apoptosis 
during development (Conradt and Horvitz, 1998). Egl-1, which is regulated 
transcriptionally, was found to relieve Ced –4 and –3 pro-apoptotic activities by 
inhibiting Ced –9 functions. 
 
Further studies on the signal transduction pathway demonstrated that in healthy cells 
Ced-9 binds to Ced-4, preventing it from activating Ced-3, a cysteine protease. In the 
event when apoptosis occurs, Ced-9 inhibition on Ced-4 is lifted by Egl-1. This in turn 
releases Ced-4 which activates Ced-3 resulting in apoptosis (Horvitz, 2001; Spector et al., 
1997b).  Diagram 1 shows the schematic flow chart of the C.elegans apoptotic pathway. 
 
The studies of the apoptotic machinery in C.elegans were extended to higher organisms. 
Within the last decade, researchers have identified the mammalian homolog of Egl-1, 
Ced-9, -4 and –3. They are namely, BH3 only Bcl-2 family proteins (Conradt and 




1999) and caspases (Xue et al., 1996), respectively. These proteins share either function 
or domain homology with their C.elegans counterparts.  
 









Diagram 1 Conservation of apoptotic pathway in C.elegans and mammalian system. Death signal 
transduce through the conserved apoptotic machinery ultimately leads to cysteine proteases activation 
which give rise to the morphological changes during apoptosis.   
 
1.3. Extrinsic and Intrinsic apoptotic pathway  
Apoptosis induction in mammalian system is generally classified into either extrinsic or 
intrinsic pathways (Lawen, 2003). The former transduces the death signal intracellularly 
upon the ligation of death ligands on the surface to the transmembrane death receptors 
(DR). Each class of death receptors is activated by specific ligands. Death signals 
received by the death receptors are transduced into the cells leading to the activation of 












In intrinsic pathways, death signals arise from within the cell. Cells with irreversible 
DNA damage, endoplasmic reticulum stress, or mitochondrial stress, respond by 
activation of the apoptotic pathways. The death signal is transduced from the nuclei or 
cytoplasm, via the Bcl-2 pro-apoptotic family member, to the mitochondria, which 
further govern the apoptotic process. Both extrinsic and intrinsic pathways converge at 
the activation of caspases (Lawen, 2003).  
 
Diagram 2 summarises the signal transduction pathways by both the extrinsic and 
intrinsic cue. Individual components will be discussed in the following sections starting 











Diagram 2 The extrinsic and intrinsic apoptotic signal transduction pathways. Apoptosis is activated either 
by the extrinsic pathway (on the left) through the death receptors or the intrinsic pathway (on the right) 




1.3.1. Role of caspases in apoptosis 
Caspases were first identified for their ability to cleave interleukin-1β converting enzyme 
or ICE (Thornberry et al., 1992). Overexpression of ICE protein in fibroblasts resulted in 
apoptosis (Miura et al., 1993). The sequence homology and conserved pentapeptide 
sequence (QACR(N/Q)G) at the active site has led to the identification of at least 14 
family members (Chan and Mattson, 1999). Caspases also share structural and functional 
homology with Ced-3 protein of the C.elegans (Yuan et al., 1993). Both belong to a 
family of cysteine proteases. The family members range from 32 kDa to 56 kDa. Table 1 
summerises the list of mammalian caspases identified.  
 
Caspases are synthesised as proenzyme, consisting of a prodomain, a large subunit (P20) 
connected to the small subunit (P10) by a short linker region (Chan and Mattson, 1999). 
Caspases display tetrapeptide specificity in their substrate recognition (refer to table 1), 
cleaving the target protein after the aspartyl residue at the P1 position (Alnemri et al., 
1996). The enzymes are activated upon proteolysis to generate P20 and P10 subunits. 
Crystal structures of caspase-1 and –3 revealed a heterodimer of the 2 subunits, with two 
P10s interacting with each other when the enzymes are active (Cohen, 1997; Walker et 
al., 1994). The proteolytic activity of caspases is achieved by the cysteine residue at it 
active site. Point mutations in the catalytic site of the enzyme resulted in inability for 
cells to die (Kumar et al., 1994; Miura et al., 1993). Concomitantly, overexpression of 





Caspases can be classified based on their activity in the apoptotic cascade, substrate 
directed studies, and phylogenetic studies (Talanian et al., 1997; Thornberry, 1997). 
Generally, the family of enzymes can be divided into 3 groups. Firstly, the ICE family of 
caspases plays an important role in inflammatory response. This group of caspases 
includes caspases -1, -4, -5, -11, –13, and -14. They function as cytokine-processing 
enzymes and cleave substrates with consensus site of (YWL)EHD.  The second group of 
caspases cleaves their target proteins with DXXD on the cleavage site. This group is also 
known as CPP32 –like family and they are made up of caspase –2, -3, and -7. And the 
last group which includes caspase –6, -8, -9, and –10, show specificity for branched-
chain aliphatic amino acids at P4 position (Grutter, 2000). 
 
Caspases can also be classified based on their activity on the apoptotic pathway, and this 
correlates to the presence of protein-protein interaction domain on the prodomain of the 
enzymes. Caspases –2, -8, -9, and –10 are known as upstream caspases or initiator 
caspases. These caspases process a large prodomain with specific protein-protein 
interacting domains. Two death effector domains (DED) on the prodomain of caspase –8 
and –10 are required for interaction with the DR adaptor proteins such as TRADD and 
FADD via DED-DED interaction, resulting in DISC (death inducing signaling complex) 
formation (see later) (Srinivasula et al., 1996). The CARD (caspase recuitment domain) 
found on the caspase-9 and -2 protein share homology to the both Apaf-1 protein in 
mammals and Ced-4 protein of the C.elegans (Zou et al., 1997). In the mammalian 
system, caspase-9 CARD domain is required for its interaction with Apaf-1 in the 




up of several copies of Apaf-1, dATP, cytochrome c, and caspase-9 (Li et al., 1997). The 
upstream caspases recruited either to the DISC or apoptosome complex, via these 
domains, are activated in trans by cleavage at the P20 and P10 linker region. Like its 
downstream family members, upon activation, the heterotetramers will in turn be released 
to the cytoplasm where they activate the downstream caspases.  
 
Table 1. Summary of mammalian caspase family 
 
Caspase  Species  size (kDa) substrate cleavage sub-cellular               
                            recognition site  localisation 
 
Caspase –1 Human  45  WEHD   nucleus, cytoplasm 
Caspase –2 Human  48  DEHD   nucleus, cytoplasm, 
         mitochondria 
Caspase –3 Human  32  DEVD   cytoplasm, mitochondria 
Caspase –4 Human  43  (W/L)EHD  cytoplasm 
Caspase –5 Human  46  (W/L)EHD  cytoplasm 
Caspase –6 Human  34  VEHD   cytoplasm 
Caspase –7 Human  35  DEVD   cytoplasm, mitochondria, 
         endoplasmic reticulum 
Caspase –8 Human  55  LETD   cytoplasm  
Caspase –9 Human  48  LETD   cytoplasm, mitochondria 
Caspase –10 Human  55  LEHD   cytoplasm 
Caspase –11 mouse  43  LEHD   cytoplasm 
Caspase –12 mouse  48  LEHD   cytoplasm 
Caspase –13 mouse  43  LEHD   cytoplasm 
Caspase –14 mouse  29.5  LEHD   cytoplasm 
                                           
                                                                            Adapted from Chan and Mattson (Chan and Mattson, 1999) 
 
The other groups of caspases are the downstream caspases or executioner caspases. This 
includes, caspase-3, -6, and –7. Unlike their initiator family members, this group of 
caspases has short prodomains without a protein-protein interaction domain. They are 
activated by the initiator caspases. As the name implies, these caspases are proteolysed 
when activated and proceed to disintegrate the dying cells by cleaving proteins in the 
cytoskeleton network, the repair system, the transcription, and translation systems of the 




prepares dying cells to be uptaken by phagocytic cells resulting in the hallmarks of 
apoptosis (Salvesen, 2002). 
 
Table 2. List of caspase substrates and their cleavage sites 
Substrate    Cleavage site 
Cytoskeleton proteins 
 Actin    ELPD_G 
 αII spectrin   DETD_S/DSLD_S 
 βII spectrin   DEVD_S 
 Vimentin    
Signaling proteins 
 NF-κB P50 subunit  DVSD_S 
  P65 subunit  DTDD_G/ASVD_N/DCRD_G 
 Stat 1    MELD 
 Protein phosphosphatase 2A DEQD_S 
Phospholipase A2  DELD 
RasGAP    DELD_S/LLGD_G 
MEKK-1   DTVD_G 
PKCδ    DMQD_N 
PKCθ    DEVD_K 
Akt/PKB   DEVD_K 
Nuclear matrix 
 Lamins A   VEID_N 
 Lamins B1   VEID_S 
 Lamins C   VEID_N 
DNA repair enzymes and cell cycle 
 PARP    DEVD_G 
 Retinoblastoma protein(Rb) DEAD_G 
 Mdm 2    DVPD_C 
 Cdc 27 
 CDK inhibitors P21Cip/Waf1 DHVD_L  
     P27Kip1 DPSD_S 
 Hu DNA fragmentation factor DAVD_T 
 Mu ICAD   DEPD_S 
Others 
 Calplastatin   ALDD_L/LSSD_F 
 Glutamate receptor   
Bcl-2    DAGD 
 Bcl-xL    
 Bid    LQTD_G/IEPD_S 
 Rabaptin-5   DESD_F/VGAD_S 
 Presenilins PS-1   ENDD_G/AQRD_S 
                   PS-2 
Hu, human Mu, mouse                     Adapted from Chan and Mattson (Chan and Mattson, 1999) 






Table 2 displays some of the known caspase substrates. Caspase-3 cleaves inhibitors of 
DNA fragmentation factor (DFF) relieving the protein to degrade the nucleic acid, giving 
rise to the DNA laddering hallmark. 
 
1.3.2. Role of mitochondria in apoptosis 
Research on the caspase activation revealed the importance and participation of the 
mitochondria in the apoptotic process.  Mitochondria were well studied for their function 
as the powerhouse of the cell. The electron transport chain protein complexes reside on 
the inner membrane, creating high proton potential between the intermembrane space and 
the matrix. This difference in potential in turn drives the ATPase generating ATPs used 
by the mammalian system for energy (Newmeyer and Ferguson-Miller, 2003).  
 
The discovery that one of the electron transport chain proteins, cytochrome c, by Liu et 
al. in 1996, is involved in apoptotic process, gives a complete new function to this 
organelle (Liu et al., 1996). The release of cytochrome c from the mitochondria triggers 
the formation of the huge apoptosome complex that is prerequisite for the auto-
proteolysis and self-activation of caspase-9. This in turn activates the downstream 
caspases, amplifying the death-signaling cascade. 
 
Followed by the elucidation of the role of cytochrome c in apoptosis, several other 





Smac/Diablo was discovered by two independent groups of researchers in 2000. The 
mitochondrial protein was shown to localise in the mitochondria in physiological 
condition. Upon apoptosis induction, the protein translocates to the cytoplasm, relieving 
caspase activities by physically removing the Inhibitors of Apoptosis (IAPs) (see later) 
from the caspases (Du et al., 2000; Verhagen et al., 2000).  
 
Omi/Htr2A is a serine protease localising in the mitochondria as well. In the event of 
apoptosis triggered by staurosporine (kinase inhibitor), overexpression of death ligand 
(Trail) or tBid (pro-apoptotic protein), the serine protease is released from the 
mitochondria together with cytochrome c (Verhagen et al., 2002). Reducing Omi protein 
level with silencing RNA (siRNA) protects cells from apoptosis induced by Trail ligand 
and etoposide (Srinivasula et al., 2003). It was hypothesised that Omi functions as an 
apoptogenic factor by degrading IAPs, relieving caspase inhibition (Yang et al., 2003).  
 
AIF (Susin et al., 1999) and Endonuclease G (Li et al., 2001) are nucleases released from 
the mitochondria in the event of cell death. Both proteins promote caspase-independent 
apoptosis characterised by large molecular weight chromatin fragmentation.  
 
By far, the mechanism by which these apoptogenic factors of various sizes released from 
mitochondria is not clear. There are few models proposed by different groups of 
researchers based on their data. The first model proposed the release of these factors from 
the existing permeability transition pores (PTP) (Vyssokikh and Brdiczka, 2003). PTP is 




nucleotide translocase (ANT), and cyclophilin-D (Granville and Gottlieb, 2003; Madesh 
and Hajnoczky, 2001). It served as the entry and exit point for the small metabolites and 
adenine nucleotides. Others have shown that Bax, a proapoptotic Bcl-2 protein, upon 
interacting with VDAC of PTP, resulted in the release of cytochrome c (Narita et al., 
1998; Shimizu et al., 1999). However, the different sizes of the apoptogenic factors 
released from the mitochondria led one to question if the pore size of the PTP is 
permissive for their release in response to death induction. Electron microscopy has 
shown the swelling mitochondria with expanded matrix (Wakabayashi and Karbowski, 
2001). It was proposed that swelling of the mitochondria might be the causative effect of 
the release.  
 
The other model of apoptogenic proteins release is based on the homology of Bax to 
porin, a channel forming protein. It was suggested that Bax oligomerised and inserted 
itself onto the mitochondrial outer membrane. This resulted in a pore structure that allows 
the apoptogenic factors to escape to the cytosol where they activate either a caspase-
dependent or independent apoptosis (Nouraini et al., 2000). 
 
Mitochondria play an important role of sequestering these apoptogenic proteins in 
physiological conditions and co-ordinate their release in the presence of death signal. In 
order to control these functions, mitochondria integrate information converged by the 




































Diagram 3 The role of mitochondria in apoptosis. Mitohondria provide a platform for the integration of 
death and survival signals. The apoptogenic factors released from the organelle activate caspase cascade 
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1.3.3. Role of Bcl-2 family proteins in apoptosis 
Bcl-2, also known as B-cell lymphoma 2 protein was first identified in 1988 by Vaux et 
al. for its role in follicular lymphoma (Vaux et al., 1988).  It functions as an anti-
apoptotic protein in tumorgensis, promoting cell survival.  It shared homology to the 
C.elegans Ced-9 protein (Hengartner and Horvitz, 1994b). The protein is made up of a 
series of globular bundles of five α-helices surrounding two central helices forming a 
hydrophobic pocket. The Bcl-2 homology domain (BH) is highly conserved among their 
family members.  Bcl-2 protein is made up of 4 BH domains, namely, BH1-4, while the 
other members in the family possess at least the BH3 domain (Opferman and Korsmeyer, 
2003) (see Table 3).  
 
To date, there are at least 20 members in the Bcl-2 protein family. They are generally 
classified into 2 groups, namely the anti-apoptotic members, and the pro-apoptotic 
members. The anti-apoptotic members consist of Bcl-2, Bcl-xL, Bcl-w and Mcl-1. The 
pro-apopototic proteins include Bid, Bad, Bax, Bak, Bim, Bmf, and more (Borner, 2003). 
The pro-apoptotic family members can be sub-divided to Bax-like proteins such as Bax 
and Bak or BH3 only protein, Bcl-2 family proteins with single BH3 domain (table 3).  
 
Studies have shown that BH3-only proteins, such as Bad and Bid, upon death signaling, 
undergo translocation from the cytosol to the mitochondria surface (Luo et al., 1998; 
Yang et al., 1995). These proteins act as messagers for apoptosis, interacting with the 





















Adapted from Scorrano et al. (Scorrano and Korsmeyer, 2003) 
 
The BH3 domain of the BH3-only proteins, inserted itself into the hydrophobic groove of 
the Bcl-2 or Bcl-xL leading to the inhibition of these proteins by physically preventing 
their interaction with the Bax- like family proteins such as Bax and Bak (Luo et al., 1998; 
Yang et al., 1995). The two proteins subsequently oligomerise and insert themselves onto 
the outer membrane of the mitochondria, providing pores for the exit of apoptogenic 




































Bak -/- cells to undergo apoptosis even in the presence of Bad or Bim (Zong et al., 2001).   
The interaction between the death and survival signals on the mitochondria will 
ultimately determine whether mitochondrial apoptogenic factors will be released. These 
factors then indirectly control the downstream activation of caspases. 
 
1.3.4. Role of the death receptors in apoptosis 
DR are transmembrane proteins belonging to the Tumor necrosis factor (TNF)/nerve 
growth factor (NGF) receptor superfamily (Ashkenazi and Dixit, 1998). The DR family is 
made up of TNF receptor, Fas/CD95 receptor, DR3, DR4, and DR5. Each member of 
receptors is activated upon the engagement of specific ligands. Tumor necrosis factor 
(TNF), Fas/CD95 ligands, TRAMP, and TRAIL, ligate to TNF receptor, Fas/CD95 
receptors, DR3, and DR4, respectively (Ashkenazi and Dixit, 1998). The DR comprise of 
extracellular ligand binding domains with cysteine rich regions and a cytoplasmic tail. 
DRs such as TNF and Fas receptors shared the 68 amino acids protein-protein interaction 
domain termed the Death domain (DD) (Crowe et al., 1994; Tartaglia et al., 1993), on the 
cytoplasmic side of the receptor that participate in the recruitment of the intracellular 
interacting protein such as FADD (Fas associating protein with death domain) (Boldin et 
al., 1996) and TRADD (TNF receptor associated death domain) (Hsu et al., 1995). These 
adaptor proteins possess DD on the C-terminal that is involved in the interaction with the 
DR’s DD. Several other proteins with homologous DD include RIP (receptor interacting 
protein) (Kelliher et al., 1998), RAIDD and MADD (Cryns and Yuan, 1998).  On the N-
terminal end of these proteins is the presence of another protein-protein interaction 




such as caspase -2 and -8 that share the same domain (Boldin et al., 1996). Engagement 
of the death ligands to the DR triggered a series of protein recruitment and the subsequent 
formation of DISC, comprising of the DR, adaptor proteins and caspases (Kischkel et al., 
1995).  
 
The formation of the DISC increases the local concentration of caspase-8. When in close 
proximity, the caspases are activated via proteolysis in trans. The activated caspase-8 was 
released into the cytosol where they cleave substrates such as Bid protein or caspase-3, 
depending on cell types (diagram 2) (Fulda et al., 2001). For type I cells, the activation of 
caspase –8 at the receptor complex releases the proteases to the cytosol in which it is 
activated via cleavage of casapse-3. This death signal from the DR results in full caspase 
cascade activation and the apoptotic hallmarks. In type II cells, activation of apoptosis via 
DR resulted in activation of caspase-8, which cleaves the Bcl-2 pro-apoptotic family 
member, Bid, at the N-terminal end. The C-terminal half of the protein or commonly 
known as truncated Bid (tBid), translocates to the mitochondria to activate the 
mitochondrial- dependent apoptotic cascade (Li et al., 1998; Luo et al., 1998).   
 
In summary, in the presence of death signals, these ligands bind and induce receptor 
trimerisation. This is followed by recruitment of cytosolic receptor interacting proteins. 







1.4. Apoptosis regulation 
Apoptosis of cells is the result of multiple steps of protein engagement and proteolysis. 
Since both excessive as well as limited apoptosis could have an adverse effect in proper 
development and homeostasis in an organism, it is not surprising that there are different 
levels of control within the apoptotic cascade. In this section, two forms of regulation will 
be discussed. 
 
1.4.1. Regulation I: Caspase cascade 
Caspases play a very important role in apoptosis. The hallmarks of membrane blebbing, 
DNA laddering are some examples of the actions of caspases. The family of caspases 
formed a feedback amplification system whereby apoptosis can be efficiently executed. 
Recent identification of caspase upregulation in different diseases reinforce the role of 
these proteases in maintenance of homeostasis (Ali et al., 2000; Sanchez Mejia and 
Friedlander, 2001). Caspases are therefore, tightly regulated in the mammalian system.  
 
1.4.1.1. Activation of caspases 
In the physiological condition, caspases are synthesised as a zymogen. The nature of 
activation provides the first line of regulation. The enzymes remain inactive unless they 
are recruited to form the DISC or apoptosome, in the event where death signals 
transduced through the extrinsic or intrinsic pathway. At the complexes, the proenzymes 
interact with each other and proceed to activate the caspase cascade. Therefore, to 




proteins, such as cytochrome c, which reside within the mitochondria in healthy cells. 
This, tightly controls and prevents caspases from activation, thus, controlling apoptosis.  
 
1.4.1.2. Interaction with inhibitors and non-functional caspase analog 
Another system that governs the caspases is the inhibitor of apoptosis (IAPs). 
IAPs were first identified in baculovirus. Op-IAP or baculoviral IAP interfere with the 
apoptosis process in the host, blocking the cell death machinery (Deveraux et al., 1998).  
IAP proteins consist of at least one baculoviral IAP repeat domain or BIR at the N-
terminal, which is encoded by 70 amino acids. Some IAPS contain a RING domain at the 
C-terminal (Salvesen and Duckett, 2002). The inhibitory role of IAPs is conserved from 
virus to nematode and mammalian system and the presence of BIR domain is necessary 
and sufficient. There are five members of mammalian IAPs. They are namely, XIAP, 
cIAP-1, cIAP-2, NAIP and survivin (Salvesen and Duckett, 2002). The former three IAPs 
contain three BIR domains and the RING finger while NAIP and survivin possess only 
BIR domains. XIAP, unlike the other members in the family, is expressed ubiquitously 
except in blood leucocytes and is considered the most potent of all members and it 
interacts with procaspase-9 and activated caspase -7 and –3 via the BIR domains, 
preventing their activation and proteolytic activities respectively (Roy et al., 1997).  
 
IAPs with RING finger possess E3 ligase activity (Deveraux and Reed, 1999). The 
apoptotic inhibition is achieved by targeting the bound caspases for ubiquitination and 
subsequent removal via proteosome. Although potent, the IAPs inhibition on caspases 




2000; Verhagen et al., 2000). Smac/Diablo shares function homology with the 
Drosphila’s proteins, Reaper, Hid and Grim, which displaces Drosphila’s IAP (DIAP) 
from caspases in the event of apoptosis activation.  
 
As discussed in the earlier section, caspase -8 activation occurs upon recruitment to the 
DISC after the enagement of death ligands to the DR. This recruitment event takes place 
via the interaction of the DED domains on the caspases and adaptor proteins, TRADD or 
FADD. In the cells, the analog of caspase –8, known as FLIP, which is structurally 
similar to caspase –8 except it does not possess the protease activity, was shown to 
associate with the DISC and thus, preventing caspase activation (Scaffidi et al., 1999; 
Shu et al., 1997). 
  
1.4.1.3. Phosphorylation of caspases 
More recently, researchers have identified the phosphorylation of procaspases prevented 
the enzymatic activation and activity (Allan et al., 2003). Allan et al. had shown both in 
vitro and in vivo that procaspase –9 can be phosphorylated at threoine 125 by ERK. Upon 
phosphorylation, caspase-9 is inhibited from autoprocessing and is inactive in caspase-3 









1.4.1.4. Interaction with another proteolytic system - calcium activated cysteine 
proteases, calpains  
In this work, we identified calpain, a calcium-activated protease, can negatively regulate 
caspases. Alteration of intracellular calcium level has been implicated in both promoting 





Diagram 4 Schematic structure of calpain II. The protease is made up of a large catalytic subunit with Cys 
at the active site and a small regulatory subunit. Both subunits consist of calcium-binding EF-hands. Upon 
binding to calcium, proteolysis occurs on the N-terminals of both subunits, activating the enzyme. 
 
Calpains, like caspases, belong to the family of cysteine proteases and are synthesed as a 
zymogen (Goll et al., 2003). The protein is made up of 80 kDa large subunit and a 30 
kDa small subunit which is shared by the different family members. The large subunit is 
made up of the catalytic domain and calcium-binding EF hands, while the small subunit 
functions as a regulatory partner (Blanchard et al., 1997; Jeong et al., 1997; Sorimachi et 
al., 1994). In the presence of calcium, the enzyme undergoes autoproteolysis at the N-
terminal of both small and large subunits, resulting in its activation (Goll et al., 1992). 
The calpain family is made up of several tissue specific calpain (n-calpains), µ-calpain 
and m-calpain (Elce et al., 1995; Jeong et al., 1997). µ-calpain/calpain I is activated by 
micromolar of calcium while m-calpain/calpain II is activated in millimolar of calcium. 
Both calpains are ubiquitously expressed. Like caspases, calpain activity is inhibited by 
an endogenous inhibitor, calplastatin (Nagao et al., 1994). Unlike caspases, calpains do 
not recognise its substrate based on sequence specificity, rather, it is believed that calpain 









cleavage site is structural-dependent (Jeong et al., 1997). The similarities of the two 
groups of cysteine proteases are not limited to activation, they also shared some 
substrates such as actin (Brown et al., 1997; Villa et al., 1998), Protein kinase A 
(Zimmerman et al., 1996) and C (Kishimoto et al., 1989; Shea et al., 1994) and α/βII-
spectrin (Lynch and Baudry, 1987; Siman et al., 1987). 
 
Calpain activation has been intensively studied in the nervous system and muscle as these 
tissues are exposed to periodical high calcium level. Conflicting studies have shown the 
involvement of calpains in both apoptosis as well as necrosis (Porn-Ares et al., 1998). 
Furthermore, indirect interaction between the cysteine proteases has been shown (Porn-
Ares et al., 1998; Wang et al., 1998). In the event of apoptosis, calplastatin is cleaved by 
caspase-3 to promote the activation of calpain. However, the presence of direct 
interaction between the two proteases was not investigated. Recently, we and others have 
demonstrated the ability of calpain to cleave some of the caspases (Chua et al., 2000; 
Wolf et al., 1999).  
 
1.4.2. Regulation II: Mitochondria regulation 
In the central of apoptotic dogma, cytochrome c, one of the apoptogenic factors, released 
from the mitochondria, plays a very important role in the activation of caspase cascade in 
response to both intrinsic and some extrinsic (Type II cells) cues (Barnhart et al., 2003). 
Being in the upstream of caspase cascade, regulation of mitochondrial apoptogenic 
factors release becomes an important control for the apoptotic process. Mitochondrion, as 




(Bcl-2 anti-apoptotic members) signals. Regulation of mitochondrial cytochrome c and 
other apoptogenic proteins release therefore plays an important role in the regulation of 
apoptotic signal transduction.  
 
1.4.2.1. Bcl-2 family member  
Bcl-2 family members are subclassed into anti-apoptotic and pro-apoptotic members. The 
interaction between themselves or with each other, determines the outcome of the death 
signal transduction to the mitochondria and whether apoptogenic factors will be release. 
  
1.4.2.1.1. Anti-apoptotic Bcl-2 members 
This family of the anti-apoptotic proteins which consist of Bcl-2, Bcl-xL and others 
(Borner, 2003) are known to be membrane bound. They can be found on the 
mitochondrial outer membrane, endoplasmic reticulum and nuclear membrane. These 
proteins when overexpressed, protect mitochondria integrity and prevent the release of 
apoptogenic proteins that can lead to caspase activation. High level of Bcl-2 in cells is 
often associated with cancer formation (Vaux et al., 1988). The primary function of the 
anti-apoptotic Bcl-2 proteins is thought to physically interact and form heterodimers with 
both the pro-apoptotic and the anti-apoptotic protein. The BH1, 2 and 4 domains are 
required for its anti-apoptotic effect (Huang et al., 1998; Shimizu et al., 2000b) which 






Another function of this group of proteins is through interaction with VDAC, voltage- 
dependent anion channel, an evolutionarily conserved molecule required for permeability 
transition that allows metabolites to gain entry or exit the mitochondria. In 
proteoliposome (Shimizu et al., 1999) and electrophysiological studies (Shimizu et al., 
2000a), the Bcl-2 protein interacts with VDAC and closes the channel, preventing the 
release of apoptogenic protein release to the cytoplasm. Although the exact mechanism of 
how these anti-apoptotic proteins work is currently not clear, both sequestering the pro-
apoptotic proteins on the surface of mitochondria and closing the VDAC channel, aids in 
the maintenance of mitochondrial integrity and importantly, inhibits untimely apoptosis 
activation. 
 
1.4.2.1.2. Pro-apoptotic Bcl-2 members  
Mitochondria membrane integrity governed by the Bcl-2 anti-apoptotic protein can be 
challenged to release the apoptogenic factors by the pro-apoptotic family proteins such as 
tBid and Bad (Luo et al., 1998; Yang et al., 1995). These cytosolic proteins translocate to 
mitochondria where they allosterically interfere wth Bcl-2 and Bcl-xL to allow Bax and 
Bak oligomerisation and subsequently the release of cytochrome c to activate caspase –9 
cascade (Wei et al., 2000; Yang et al., 1995). Therefore, the regulation of Bcl-2 anti-
apoptotic family members play an important role in the regulation of apoptogenic factors 
released from mitochondria.  
 
As discussed previously, translocation of BH3-only proteins is important to relieve the 




presence of additional protein processing such as phosphorylation of Bad and cleavage of 
Bid that play an important role in keeping the proteins in anti-apoptotic state. 
 
Phosphorylation of Bad 
Bad is sequestered by phosphorylation in the cytosol, preventing its association with Bcl-
2 or Bcl-xL on the mitochondrial surface (Zha et al., 1996). In the physiological condition, 
Bad is phosphorylated by a variety of kinases at serine 112, 136 and 155 (Datta et al., 
2000). The phosphorylated state resulted in high affinity binding to the 14-3-3 protein 
sequestering the protein to cytoplasm, thus unable to inhibit Bcl-2 anti-apoptotic 
function. However, upon death signal transduction, Bad is rapidly dephosphorylated 
which relieves it from 14-3-3 physical inhibition. Dephosphorylated Bad translocates to 
the mitochondrial surface, binds to Bcl-2, which allows the pro-apoptotic Bax and Bak to 
transduce the death signal to the mitochondria for the release of apoptogenic factor like 
cytochrome c.  
 
Proteolysis of Bid 
Unlike Bad which is regulated by phosphorylation, Bid exerts its apoptotic function only 
when cleaved by caspase –8 during the DR induced apoptosis in type II cells. Only the 
exposed truncated C-terminal of the protein translocates to mitochondria where it inhibits 
anti-apoptotic Bcl-2 proteins, working like Bad (Li et al., 1998; Luo et al., 1998; Lutter et 
al., 2001; Wei et al., 2000). Therefore, Bid regulation is similar to caspases, where 





1.4.2.2. Mitochondrial translocation as initiation of apoptosis 
As discussed above, mitochondrion not only function as the powerhouse of the cells. It 
also sequesters apoptogenic proteins like cytochrome c, Smac/Diablo, within its 
intermembrane space, preventing untimely activation of caspases and apoptosis. The 
mitochondrial outer membrane serves as a platform for pro- and anti-apoptotic signals 
integration. Therefore, the regulation of cytoplasmic pro-apoptotic proteins translocation 
to mitochondria is important in regards to the initiation of apoptosis. 
   
1.4.2.2.1. Bcl-2 proteins 
During the early stages of apoptosis, the release of cytochrome c is triggered by the 
physical interaction between the anti-apoptotic and the BH3 only pro-apoptotic Bcl-2 
members on the mitochondria. The insertion of BH3 domain physically prevents the Bcl-
2 and Bcl-xL from binding the Bax like proteins such as Bax and Bak. In the double 
knock out of Bax-/- Bak-/-, cells are resistant to apoptotic induction, suggesting that their 
presence on the mitochondria are necessary (Zong et al., 2001). Bax and Bak oligomerise 
and form pores where the apoptogenic protein tranlsocate into the cytosol to activate 
caspases. 
 
Translocation of these pro-apoptotic factors to the mitochondria serves an important role 
in the initiation of the caspase cascade and apoptosis. Other than being prevented from 
translocation by phosphorylation status or proteolysis as discussed above, the structural 





Bax, a pro-apoptotic protein that triggers massive cell death when overexpressed, has a 
21 amino acid mitochondrial localisation signal at the C-terminal end of the protein 
(Wolter et al., 1997). Deletion of this segment abolished the ability of the protein to be 
inserted into the mitochondria during apoptosis (Wolter et al., 1997). Serial mutational 
studies by Nechushtan et al. later demonstrated that the point mutation of serine 184 to 
aspartic acid or glutamine at the C-terminal not only abolishes Bax protein mitochondrial 
insertion but also its apoptotic-inducing ability. Concomitantly, the deletion of serine 18 
resulted in enhanced mitochondrial insertion and cell death (Nechushtan et al., 1999). 
Together with data from Goping et al., (Goping et al., 1998), who showed the 
requirement of the N-terminal is critical for Bax sub-cellular localisation, Nechushtan 
proposed that the mitochondrial-targeting signal is hidden when the N and C-terminal of 
the protein interact with each other resulting in a closed conformation. Upon apoptosis 
induction, the N-terminal restriction is lifted exposing the C-terminal mitochondrial-
localising signal. 
 
1.4.2.2.2. Non-Bcl-2 family proteins 
Direct signaling to the mitochondria via translocation is not restricted to Bcl-2 family 
members, as several other proteins such as the transcription factor TR3 (Li et al., 2000) , 
the Peutz-Jegher gene product LKB1 (Karuman et al., 2001) and more recently, p53 were 
shown to translocate into mitochondria, thereby inducing apoptosis. 
 
TR3 is a transcription factor belonging to the immediate-early response gene and an 




demonstrated that the transcription factor translocates from the nucleus to mitochondria 
to induce cytochrome c release and apoptosis in response to apoptotic induction by TNF 
and etoposide. The mechanism by which TR3 induces apoptosis upon translocation is not 
clear. However, only the mitochondrial-targeting but not its DNA binding and 
transactivation domain, is required for its death-inducing effect (Li et al., 2000).  
 
Peutz-Jegher gene product LKB1, is a serine/threonine kinase. The kinase is mutated in 
Peutz-Jegher syndrome (PJS). The protein localises to cytoplasm and nucleus in healthy 
cells and translocates to mitochondria during apoptosis. In the patients with PJS, there is 
a reduction in LKB1 level concomitantly with low apoptosis in the pyknotic intestinal 
epithelial cells. It was proposed that LKB1 plays an important role upon translocation to 
mitochondria, inducing apoptosis (Karuman et al., 2001). 
 
The most recent addition to list of protein translocating to mitochondria, inducing 
apoptosis is p53, the tumor suppressor gene (Mihara et al., 2003). It was shown that p53 
translocated to the organelle in thymocytes upon irradiation. p53 in the mitochondria 
interacts with Bcl-2 and Bcl-xL, resulting in membrane permeabilisation, cytochrome c 
release, and apoptosis. 
 
All three non-Bcl-2 proteins, other than their established known function, translocate to 
mitochondria and induce cytochrome c release in response to death signal, suggesting 





1.4.2.2.3. Mitochondrial translocation of cofilin 
 
In this work, we used a proteomic approach and identified a cytoskeletal protein 
translocating to mitochondria at the early phase of apoptosis. The protein was identified 



















Chapter 2: Introduction II 
 
2.1 Cytoskeleton  
The actin cytoskeletal network plays an important role in cellular structural stability, cell 
shape change, cytokinesis and chemotaxis (Kaibuchi et al., 1999). The cytoskeleton is 
composed of microtubules, intermediate filaments, and actin filaments (Kaibuchi et al., 
1999). Microtubules form the largest structure of the three with diameter of 25 nm. It is 
centrally organised and found in the entire cell. The intermediate filaments, on the other 
hand, concentrate around the cell bodies. The actin filaments are the smallest structures 
of all. They are generally about 6 nm and are a subclass to actin stress fibers and 
lamellipodia.  
 
2.1.1. Actin regulation by cofilin 
In presence of extracellular signal stimulation such as growth factors, hormones, or 
foreign particles, the peripheral membrane bound small GTPase proteins belonging to the 
Rho family are activated. Rho small GTPase family consists of Rac, Cdc42 and Rho. 
Activation of Rac results in lamellopodia formation (Ridley et al., 1992) and actin 
polymerisation (Machesky and Hall, 1997). Cdc42 is found to be associated with 
formation of filopodia structure (Kozma et al., 1995; Nobes and Hall, 1995). Rho 
participates in the formation of stress fibers (Ridley and Hall, 1992). They are also 
required for the maintenance of cell shape (Paterson et al., 1990) and motility (Takaishi et 
al., 1994). The Rho small GTPase proteins are GTP/GDP binding proteins. In GTP bound 




PAK and ROCK (diagam 5). The kinases in turn relay the signal from the small GTPases 
intracellularly, resulting in cytoskeleton rearrangement. The signal transduced from the 
cell surface is shut down by GTP hydrolysis, promoted by GTPase-activating proteins 
(GAPs)(Bishop and Hall, 2000). Rho family proteins are reactivated when the guanine 
necleotide exchange factors (GEFs) catalysed the exchange of GDP for GTP (Bishop and 
Hall, 2000). 
 
2.1.1.1. Cofilin regulation 
Cofilin was first identified for its function in actin depolymerisation and belongs to the 
family of actin depolymerisation factor (ADF) (Nishida et al., 1984). ADF are present in 
yeast to human and the family members share sequence homology (Maciver and Hussey, 
2002). The protein is made up of 166 amino acids and is ubiquitously expressed and 
abundant in all tissues. On the C-terminal end of the protein (106-125 aa) is the actin 
depolymerisation signature (Yonezawa et al., 1991). There is also a presence of a 
nuclear-localisation signal between 30-34 aa (Samstag et al., 1994).  
 
Cofilin is well studied for its role in actin depolymerisation. In its dephosphorylated state, 
cofilin binds to the pointed end of filamentous actin (F-actin) in a 1:1 ratio, 
depolymerising the F-actin to monomeric form (G-actin) by forming a kink (Maciver and 
Hussey, 2002). The activity of cofilin is negatively regulated by LIM kinases, which 
phosphorylate cofilin on its third serine residu, thereby inactivating its depolymerisation 
activity (Arber et al., 1998; Yang et al., 1998). LIM kinases are in turn regulated by 




et al., 1999). Schematic diagram 5 shows the signal transduction pathway of cofilin 
regulation. In the physiological condition, both the phosphorylated and dephosphorylated 
pools of cofilin exist in the cells. The dephosphorylated cofilin associate with the F-actin, 
which is necessary for the maintenance of cellular cytoskeletal network. Upon cell 
stimulation during chemotaxis, phagocytosis, and morphogensis, cofilin is 
dephosphorylated by phosphatases such as Slingshot (Niwa et al., 2002) and PP2A 
(Ambach et al., 2000; Bamburg, 1999), resulting in a shift to dephosphorylated form 
only. Dephosphorylated cofilin can translocate to the activated domains of the plasma 














Diagram 5 Cofilin is regulated by Rho family of small GTPase. Cofilin phosphorylation by LIM kinase  
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Other than phosphorylation, cofilin is also regulated by interaction with 
phosphatidylinositol 4,5-bisphosphate (PIP2) (Yonezawa et al., 1991) and 14-3-3 protein 
(Gohla and Bokoch, 2002). Cofilin interacts with PIP2 at its lysine 112 residues as shown 
in the mutational studies by Moriyama et al. (Moriyama et al., 1992). However, lysine 
112 although required is not sufficient. The mutational studies indicated the presence of 
other domain on the protein is required for this interaction. PIP2 negatively regulates 
cofilin by physically preventing the interaction of this protein to the F-actin at lysine 114.  
 
14-3-3 is a family of proteins first identified by Moore et al. in 1967 in the cow brain 
extract. This group of proteins acts by inhibition, stabilization or translocation 
(Rosenquist, 2003). There are seven members in human tissue and they recognise 
phosphoserine with a consensus binding sequence (Rosenquist, 2003). Recently, it was 
shown that 14-3-3ζ have high affinity for the phosphorylated cofilin, binding at residue 
20-24 at the N-terminal of the protein (Gohla and Bokoch, 2002). These data suggested 
that interaction with 14-3-3 further prevented the actin depolymerisation activity of 
cofilin. 
 
2.2. Cytoskeletal proteins and cell death 
The cytoskeletal proteins have been implicated in apoptosis due to their actin 
reorganisation function. Membrane bledding and formation of apoptotic vesicles, which 





In recent work, Rho inactivation, which leads to inhibition of LIM kinases, resulted in 
apoptosis (Bobak et al., 1997). In addition, its effector protein, ROCK I was shown to be 
cleaved during apoptosis. The truncated form becomes constitutively active, giving rise 
to the membrane bledding observed during apoptosis (Coleman et al., 2001). 
Subsequently, others have shown that overexpression of ROCK can result in apoptotic 
membrane blebbing and chromatin condensation which is caspase-independent as shown 
in the presence of caspase inhibitor zVAD-fmk or in caspase-3-deficient MCF-7 cells 
(Song et al., 2002). These studies provide an insight to the involvement of the 
cytoskeletal proteins during apoptosis, playing a role in membrane blebbing and 
chromatin packaging into the apoptotic vesicles.  
 
In contrary to the above study, Cdc42, another member of Rho family of small GTPase 
can be cleaved by both caspase-3 and caspase-7 but not caspase-6 and caspase-8. Mutant 
Cdc42 with caspase cleavage site deleted or mutated, provide resistance against Fas 
ligand-induced apoptosis (Tu and Cerione, 2001). This study suggests that cytoskeletal 
changes are late events, after caspase activation. 
 
In addition to the established function, there are some evidences that the upstream signal 
proteins may be required for apoptosis induction as well. Rac1, a member of small 
GTPase protein, mediating the organisation of the actin cytoskeleton, lipid metabolism, 
and gene transcription, has also been implicated in oncogenic transformation. 
Overexpression constitutively active Rac1 has been shown to increase cell survival in the 




from Clostridium has also provided information on the role of these cytoskeletal proteins 
and cell death. LT-IP82 which inactivates Rac, induced cell death by disruption of 
mitochondrial homeostasis resulting in decrease of mitochondrial transmembrane 
potential and cardiolipin alterations and release of cytochrome c in the cytosol. Apoptosis 
can be prevented by Bcl-2 overexpression and caspase inhibitors (Petit et al., 2003). 
Furthermore, overexpression of PAK1 and PAK4, which activate LIM kinases were 
shown to promote cell survival (Schurmann et al., 2000). Another line of evidence that 
demonstrates the relationship between the cytoskeletal proteins and apoptosis comes from 
the LIM kinase 2 knock-out mice. LIM kinase lies downstream of ROCK, which in turn 
is activated by Rho, and upstream of cofilin. In LIM kinase 2 knock-out mice, the 
spermatocytes displayed enhanced susceptibility to apoptotic stimuli, suggesting a 
correlation of the Rho/ROCK/LIM kinase/cofilin pathway in the event of apoptosis. 
 
2.3. Cofilin and stress 
Cofilin, the actin depolymerising factor, is deployed during actin reorganisation. It 
governs some of the biological processes such as motility as well as stress response such 
as phagocytosis of invading particles. Several studies have also associated the protein to 
pathological conditions such as neurodegenerative disorders. Dephosphorylated or 
activated cofilin was found in inclusions of human Alzheimer’s brain, forming rod-like 
amyloid deposite at the end of neurites, resulting in degeneration of synapses (Minamide 
et al., 2000). In another study on malignant T lymphoma by Samstag et al., blocking 
cofilin dephosphorylation by okadaic acid resulted in apoptosis induction in these 




group that identified cofilin’s nuclear-localising ability (Samstag et al., 1994), it was 
proposed that dephosphorylated cofilin carries G-actin into the nucleus in stress 
condition. The anti-DNase I activity of G-actin is prosurvival (Blikstad et al., 1978; 
Peitsch et al., 1993). Thus, by blocking dephosphorylation, this indirect prosurvival effect 
of cofilin maybe lost, resulting in cell stress.  
 
Although these studies together with others on cytoskeletal proteins implicated signal 
transduction through the Rho GTPase family and apoptosis, no direct and distinctive role 
for cofilin participation in the regulation of apoptosis was demonstrated so far.  
 
In this work, we showed the direct apoptotic effect of cofilin upon translocating to the 















Rational and Objectives 
 
Apoptosis plays an important role not only in development, as well as in adult organism, 
maintaining the homeostasis of our biological system. During this process, cells are 
committed to die once caspases are activated. The regulation of caspases is therefore 
critical in the prevention of untimed apoptotic death. Mitochondria are the other 
regulators of the apoptotic process. The organelle sequesters the apoptogenic factors such 
as cytochrome c and Smac/Diablo. The release of these proteins is dependent on 
interaction of the pro-survival and pro-apoptotic proteins on the mitochondrial surface, 
thus serving as a platform for death and survival signals.  
 
In this work, we identified (i) novel way of caspase regulation by calcium-activated 
cyteine proteases, calpains and (ii) cofilin, a cytoskeletal protein, for its pro-apoptotic 
function once translocated to the mitochondria.  
 
In chapter 4, we focus on the role of calpains, on the initial identification and elucidation 
and its negative regulation on the caspase cascade. The next chapter presents the role of 
cofilin, the actin depolymerising protein and characterised cofilin mitochondrial-targeting 







Chapter 3: Materials and Methods 
 
3.1. Antibody list 
Antibodies used    working dilution & source 
polyclonal rabbit anti-actin   1:2000; Sigma, St Louis, M0 
monoclonal mouse anti-tubulin   1:2000; Sigma, St Louis, M0 
monoclonal mouse anti-Hsp60   1:2000; Sigma, St Louis, M0 
polyclonal rabbit anti-HA    1:1000; Santa Cruz Biotechnology, Santa Cruz, CA 
      1:250 for immunofluorscence 
polyclonal rabbit anti-cofilin   1:1000; Cytoskeleton Inc, Denver, CO 
      1:200 for immunofluorscence 
polyclonal rabbit anti-Bad    1:1000; Cell Signaling, Beverly, MA 
monoclonal mouse anti-Bcl-2   1:1000; BD Bioscience, Franklin Lakes, NJ 
monoclonal mouse anti-COX-IV   1:1000; Molecular Probes, Eugene, OR 
monoclonal mouse anti-cytochrome c  1:1000; PharMingen, San Diego, CA 
      1:400 for immunofluorscence 
polyclonal rabbit anti-caspase-3   1:1000; Upstate Biotechnology, Lake Placid, NY 
polyclonal rabbit anti-caspase-7   1:2000; PharMingen, San Diego, CA 
polyclonal rabbit anti-caspase-9   1:1000;  PharMingen, San Diego, CA 
monoclonal mouse anti-spectrin   1:1000; Chemicon, Temecula, CA 
monoclonal mouse anti-calpain (small subunit) 1:2000; Chemicon, Temecula, CA 
goat anti-mouse conjugated HRP   1:5000; Bio-Rad, Hercules, CA 
goat anti-rabbit conjugated HRP   1:5000; Bio-Rad, Hercules, CA 
goat anti-mouse conjugated Alexa Fluor 488  1:500; Molecular Probe, Eugene, OR 
goat anti-mouse conjugated Alexa Fluor 568  1:500; Molecular Probe, Eugene, OR 
goat anti-rabbit conjugated Alexa Fluor 488  1:500; Molecular Probe, Eugene, OR 




3.2. Primer list 
Primers sequence 
wt  5’-Cg gAA TTC ACC ATg gCC TCC ggT gTg gCT gT - 3’ 
Cof-HA 5’-C AAg CTT TgC gTA gTC Tgg CAC gTC gTA Tgg gTA CTC gAg CAA Agg CTT 
gCC CTC Agg g -3’ 
S3A  5’-Cg gAA TTC ACC ATg gCC gCC ggT gTg gCT gT - 3’ 
S3D  5’-Cg gAA TTC ACC ATg gCC gAC ggT gTg gCT gT - 3’ 
∆N15  5’-Cg gAA TTC ACC ATg AAC gAC ATg AAg gTg CgT AAg -3’ 
∆N30  5’-Cg gAA TTC ACC ATg AAg CgC AAg AAg gCg -3’ 
∆N40  5’-Cg gAA TTC ACC ATg AgT gAg gAC AAg AAg AAC ATC -3’ 
∆N83  5’-Cg gAA TTC ACC ATg CTC TAT gAT gCA ACC TAT gAg ACC -3’ 
∆C66 5’-CCC TCg AgT gCg TAg TCT ggC ACg TCg TAT ggg TAA AgC TTg gCC CAg 
AAg ATA AAC ACC -3’ 
KQ1-5 5’-gg gCC CCC gAg TCT gCg CCC CTT CAg AgC AAA ATg ATT TAT gCC AgC 
TCC AAg gAC gCC 3’  
KQ1-3 5’-ggC gTC CTT ggA gCT ggC ATA AAT CAT TTT gCT CTg AAg ggg CgC AgA 
CTC ggg ggC CC -3’ 
KQ2-5 5’-gg gCC CCC gAg TCT gCg CCC CTT AAg AgC CAA ATg ATT TAT gCC AgC 
TCC AAg gAC gCC 3’  
KQ2-3 5’-ggC gTC CTT ggA gCT ggC ATA AAT CAT TTg gCT CTT AAg ggg CgC AgA 
CTC ggg ggC CC 
KQ3-5 5’-gg gCC CCC gAg TCT gCg CCC CTT CAg AgC CAA ATg ATT   TAT gCC AgC 
Tcc AAg gAC gCC 3’  
KQ3-3 5’-ggC gTC CTT ggA gCT ggC ATA AAT CAT TTg gCT CTg AAg ggg CgC AgA 
CTC ggg ggC CC 
Bcl-2-5  5’-C gCg gAT CCC gCg gAT TTC TCC Tgg CTg TCT CTg -3’ 




3.3. DNA methodology 
Special thanks goes to Dr. John Elce for the BL21(DE3) bacterial clone with rat m-
calpain (large subunit was cloned into pET24-CHIS6 and the small subunit was cloned in 
pAC pET) for recombinant protein production (Elce et al., 1995) and Wang X.D. group 
for human caspase –7 and -8 which were generated by cloning into Nde1 and BamH1 
sites of pET15b while caspase-9, caspase-9C287A, caspase-9D315A, caspase-9D330A 
and caspase-9∆pro were cloned into the similar sites on pET21b (Li et al., 1997). My 
gratitude to Dr Jeffery Tan and Dr Victor Yu for the pET-H-tBid and pXJ-myc c-Bcl-xL 
and –Bax. Most importantly, thank you for the excellent collaboration for the isolated 
mitochondria assay. 
 
3.3.1. Polymerase chain reaction (PCR) 
The PCR reactions were performed using the Pfu polymerase kit (Promega) according to 
manufacturer recommendations. The PCR reaction mix was set up as follows: 
         Amount added  Final concentration 
Pfu Polymerase (3 units/ µl)   1 µl     3 units 
10X Buffer     5 µl    1X 
dNTP (10 mM)    2 µl    0.4 mM 
Forward primer (50 µM)   1 µl    100 pmole 
Reversed primer (50 µM)   1 µl    100 pmole 
Template (30 ng/µl)    1 µl    30 ng 





The PCR conditions were set up as follows: 
Step Temperature Time 
1. Initial denaturation 94oC  4 minutes 
2. Denaturation 94oC 1 minute 
3. Annealing* 50-68oC 1 minute 
4. Extension+ 72oC 1 minute per kb 
5. Final extension 72oC 10 minute 
* Approximately 5oC below the Tm of primers 
+ The reaction is repeated from step 2 to 4 for 25 cycles 
 
Upon the completion of PCR reaction, for blunt end ligation, klneow/kinase reaction (see 
3.3.3.) was performed to fill overhanging ends and phosphorylate the 5’end. PCR 
products were separated using agarose gel electrophoresis (see 3.3.4.) and visualised 
using UV trans-illuminator (Vilber Lourmat). PCR fragment of the right size was excised 
and proceed with DNA elution (see 3.3.5.) before ligation to vector (see 3.3.8.). 
 
3.3.2. Site-directed mutagensis (SDM) 
Both forward and reverse primers comprising of the mutated residues were designed and 
SDM was performed using QuikChange® II Site-Directed Mutagenesis Kit (Stratagene) 
according to the manufacturer’s instruction. Briefly, PCR reaction mix was set up as 







            Amount added  Final concentration 
Pfu Polymerase (3 units/µl)     0.5 µl     1.5 units 
10X Buffer          5 µl       1X 
dNTP (10 mM)         1 µl    0.2 mM 
Forward primer (100ng/µl)   1.25 µl    125 ng 
Reversed primer (100ng/µl)   1.25 µl    125 ng 
Template (30 ng/µl)          1 µl      30 ng 
Distilled water        40 µl         - 
 
The PCR conditions were set up as follows: 
Step Temperature Time 
1. Initial denaturation 95oC 1 minute 
2. Denaturation 95oC 30 seconds 
3. Annealing 50oC 2 minutes 
4. Extension+ 72oC 12 minutes 
5. Final extension 72oC 12 minutes 
+ The reaction is repeated from step 2 to 4 for 18 cycles 
 
Upon the completion of PCR reaction, the template DNA was digested with 1 µl Dpn 1 
for 1 hour at 370C. The mutagenised plasmid recovered by elution from agarose gel after 
electrophoresis. The eluted DNA was transformed into E.coli strain, DH5α, for plasmid 






3.3.3. Klenow/Kinase reaction 
The following reaction mix was set up for klneow/kinase reaction. 
         Amount added  Final concentration 
PCR product     26 µl       - 
10X Kinase buffer      4 µl    1X 
dNTP (10 mM)      4 µl    1 mM  
ATP (10 mM)           4 µl    1 mM 
T4 Kinase (10000 Units/ml)     1 µl    10 units 
Klenow (5000 Units/ml)     1 µl     5 units 
The reaction mix was incubated in 370C for 20 minutes before heat inactivated at 720C 
for 10 minutes. 
 
3.3.4. Agarose gel electrophoresis 
10X DNA loading dye (0.1% bromophenol blue, 0.1% xylene cyanol, 40% glycerol) was 
added to the plasmid DNA to a final working concentration of 1X. 1%(w/v) agarose gel 
was prepared by dissolving 1 gram of agarose to 100 ml TBE buffer (89 mM Tris, 89 
mM Boric Acid, 2.5 mM EDTA). 0.5 µg/ml Ethidium bromide was added before 
allowing the gel to solidify on gel casting mould. The solidified agarose was submerged 
in the electrophoresis tank with TBE. DNA samples with loading buffer and 0.1µg DNA 
ladder marker were loaded in the individual wells and electrophoresed at 100 volts. The 





3.3.5. Elution of DNA from agarose gel 
DNA fragments of interest were excised from the agarose gel under UV illumination, 
using clean scapel. DNA was eluted using the QIAquick gel extraction kit (Qiagen) 
according to the manufracturer ‘s instruction. Briefly, the gel excised containing the DNA 
fragment was weighed and 3X volumn of QG buffer was added (100 mg of gel in 300µl 
of buffer. The mixture was left in 520C with occasional agitiation to dissolve the agarose 
gel. The mixture was loaded then onto the mini-column and spun at 12000 rpm on 
tabletop microfuge (Eppendorf) for 1 minute. The column was flushed with 600 µl of QG 
buffer before the addition of 600 ul of washing buffer (PE). The column was further spun 
for another 1 minute to ensure the complete removal of PE buffer before the addition of 
30 µl of elution buffer. DNA was collected into a clean eppendorf tube by centrifugation 
at 12 000 rpm for 1 minute in the microfuge. 
 
3.3.6. Restriction enzymes (RE) digestion of plasmid DNA 
The following reaction mixture was set up for RE digest: 
Plasmid DNA  0.5-1 µg 
RE enzyme(s)     0.5 µl 
10X RE buffer      3 µl 
distilled water  top up to 30 ul 
The RE digest reaction mix was incubated at 370C for at least 1 hour. The enzymes were 
removed by agarose gel electrophoresis (see 3.3.4). The digested plasmid DNA was 





3.3.7. Dephosphorylation of plasmid DNA  
1 µl or 10 units of calf intestinal phosphatase (New England Biolabs) was added to the 
RE digestion mix after specified time of digestion reaction. The reaction mix was further 
incubated for 20 minutes at 370C before subjecting to agarose gel electrophoresis. The 
dephosphorylated plasmid DNA was recovered by DNA elution (see 3.3.5). 
 
3.3.8. Ligation 
Before ligation, vector DNA was dephosphorylated to reduce possible self-ligation prior 
to ligation (see 3.3.7.). The following ligation mixture was set up: 
 
T4 DNA Ligase (400 units/µl)    1 µl 
10X buffer    1.5 µl  
Vector DNA: insert DNA  1: 8 (for blunt ligation) 
     1: 3 (for directional ligation) 
Distilled water    top up to 15 µl  
The reaction mix was left incubating at room temperature for 16 hours before subjecting 
to transformation into DH5α competent cells (see 3.3.9.). 
 
3.3.9. Transformation by KCM method 
Transformation was performed using KCM method. 8 µl of ligation mixture or 0.1 µg 
plasmid DNA was added to 50 µl of cold KCM buffer (100 mM KCl, 30 mM CaCl2 and 
50 mM MgCl2) and incubated on ice for 10 minutes. After which, equal volumn of KCM 




ice for another 30 minutes before plating on antibiotic-selective agar.  For transformation 
of Kanamycine resistant plasmid, an additional incubation with antibiotic-free liquid 
broth at 370C for 30 minutes was required before plating.  The transformants were plated 
on the selective agar and left to incubate in 370C overnight. 
 
3.3.10. Transformation by electroporation method 
Electroporation was used for transforming protein-expressing plasmid into BL21(DE3) 
competent cell. 8 µl of ligation mixture or 0.1µg plasmid DNA were incubated with 50 µl 
of BL21(DE3) cells in pre-chilled 0.2cm gap electroporation cuvette (Bio-RAD). The 
electroporation apparatus (Bio-Rad Gene Pulser II) was set to 25µF, 2.5 kV, 200 Ω and 
the pulse was applied. This was followed by the addition of 1 ml of antibiotic-free liquid 
broth. The suspension was transferred to a 10 ml tube and incubated at 370C for 1 hr. 
After which, the suspension was plated on selective agar. The transformants plated on the 
selective agar plates were incubated in 370C overnight. 
 
3.3.11. Mini-preparation of plasmid DNA 
Colonies on selective agar plates were picked into individual 2 ml selective liquid broth 
and incubated in 370C with agitation for at least 12 hours. The plasmid DNA was 
extracted by STET-boiling method.  Briefly, bacteria were spun down by centrifugation 
for 10 seconds on table-top microfuge. Cells were re-suspended in 350 µl STET buffer 
(8% sucrose, 0.5% Triton X-100, 50 mM Tris pH8.0 and 50 mM EDTA). Fresh lysozyme 
(0.6 mg/ml) was added to the re-suspended cells and boiled for 4 minutes to lyse the 




supernatant, 25 µl phenol was added and vortex to denature protein. The mixtures were 
spun again and to the supernatant, 400 µl isopropanol was added to precipitate the 
plasmid DNA.  DNA pellet collected were washed with 70% ethanol before dissolving in 
30 µl TE buffer (10 mM Tris-HCl pH 7.4 and 1 mM EDTA pH 8.0) with 10 µg/ml 
RNase. 
 
3.3.12. Maxi-preparation of plasmid DNA 
Large scale plasmid DNA were prepared using QIAGEN Plasmid Maxi Kits according to 
manufacturer’s instruction. Briefly, 400 ml DH5α containing plasmid construct were 
cultured overnight in 370C shaker. Cells were harvested by centrifugation at 4000 rpm in 
40C for 20 minutes. The bacterial pellet was re-suspended in 10 ml of P1 solution 
followed by lysis by addition of 10 ml of P2. The mixtures were inverted to allow mixing 
before neutralisation with 10 ml of chilled P3. The mixtures were mixed gently by 
inverting and left to chill in ice for 20 minutes. The cell debris were separated from the 
plasmid DNA by centrifugation at 20 000 x g for 30 minutes at 40C. The supernatant 
containing the plasmid DNA were loaded on QIAGEN-tip 500 column equilibrated 
previously with 10 ml of buffer QBT. This was followed by 2 X 30 ml of wash buffer 
(Buffer QC). Finally, the plasmid DNA was eluted with the addition of 15 ml of buffer 
QF. The eluted plasmid DNA was collected into 10.5 ml or 0.7 volumn of room-
termperature isopropanol. The plasmid DNA was precipitated by inverting the mixture 
gently. The precipitated DNA was pellet down by centrifugation at 15 000 x g for 30 





3.3.13. Preparation of KCM competent DH5α cells 
DH5α were cultured in 200 ml of antibiotic-free liquid broth to O.D 0.3-0.6. Cells were 
chilled on ice for 15-30 minutes before pellet by spinning at 4000 rpm for 5 minutes in 
40C. The pellet was re-suspended on ice in 1/20 volume of TSS buffer (10% PEG 8000, 
5% dimethyl sulfoxide, 10 mM MgCl2, 10 mM Mg2SO4, adjust pH to 6.5-6.8, filtered). 
Aliquotes of 50 µl were frozen immediately with liquid nitrogen. 
 
3.3.14. Preparation of electroporation competent BL21(DE3) cells 
BL21(DE3) were grown in 1 litre of antibiotic free liquid broth to an O.D of up to 1. 
Cells were pellet by centrifugation at 4000 rpm in 40C for 20 minutes (JB-6 rotor). The 
pellet was washed by re-suspension with 1 volumn of cold distilled water. The 
suspension was pellet again and this was followed by second wash with 0.5 volumn of 
distilled water. Finally, 2 ml of 10% glycerol was added to re-suspend the pellets and 
aliquote of 50 µl were frozen immediately with liquid nitrogen. 
 
3.3.15. Plasmid DNA sequencing 
The sequencing reactions were performed by PCR.  200 to 500 ng of plasmid DNA and 
3.2 pmol of primer were mixed in a final volume of 12 µl. 8 µl of terminator Ready 
Reaction Mix (ABI Prism) were added to the reaction mix. The sequencing reaction was 






Step 1: denaturation at 960C for 10 seconds 
Step 2: Annealing at 500C for 5 seconds  
Step 3: Extension at 600C for 4 minutes 
The reaction was repeated from step 1 to 3 for 25 cycles.  After completion of the 
reaction, the DNA was precipitated by the addition of 80 µl of 60% ethanol. Mixture was 
mixed and allowed to stand at room temperature for 15 minutes before centrifugation at 
12 000 rpm for 20 minutes. The ethanol was discarded and the pellet was washed with 
150 µl of 70% ethanol. It was then air dried and reconstituted in loading buffer (ABI 
Prism). The sequences were then resolved and read using Perkin-Elmer ABI Prism 377 
sequencer by Dr. Alice Tay’s laboratory. 
 
3.3.16. Ethanol precipitation of DNA 
Add 2.5X volumn of 100% ethanol and 1/10 volumn of 3M sodium acetate to the DNA 
solution. Precipitate DNA by inverting gently and spun down the precipitated DNA by 
centrifugation at 12 000 rpm for 15 minutes on tabletop centrifuge (Eppendorf). The 
DNA pellet was washed with 70% ethanol to remove salt completely and spinning was 









3.4. Mammalian cell culture, treatment and sub-cellular 
fractionation 
3.4.1. Cell culture  
Mammalian cell lines: COS-7, HeLa S3, and SH-SY5Y cells were cultured in Dulbecco’s 
modified Eagle’s medium (DMEM) and HL60, Jurkat and MCF-7 cells were cultured in 
RPMI 1640, supplemented with 10% heat inactivated fetal calf serum, 100 U/ml 
penicillin and 0.1 mg/ml streptomycin.  Cells were incubated in culture media in 370C 
incubator with 5% carbon dioxide.  
 
3.4.2. Apoptotic stimulation 
1X107 cells/ml HL60 and Jurkat cells or 1X106 cells/ml of SH-SY5Y and HeLa S3 were 
plated before treatment. Apoptosis was induced either by addition of 1 µM staurosporine 
(STS) or 100 µM etoposide. An equal volume of vehicle (DMSO) was used in controls. 
50 µM of caspase inhibitors (zVAD-fmk; DEVD-fmk; Enzyme Systems Products, CA) 
was added into culture 30 minutes prior to the drug treatment. 
 
3.4.3. Apoptosis assay  
Apoptosis was assessed by nuclear morphology. Cells were loaded with 1 µg/ml H-33342 
(cell permeable, blue-fluorescent chromatin stain) for 10 minutes. Apoptosis was 
characterised by scoring condensed and fragmented highly fluorescent nuclei. Each set of 





3.4.4. Whole cell lysate preparation 
Mammalian cells were harvested either by centrifugation at 600g or typsinisation with 
5% tryprsin. Cells were washed once with cold PBS and lysed in 3 volumes of SDS-lysis 
buffer (50 mM Tris-HCl pH 6.8, 100 mM DTT, 2 % SDS).  
 
3.4.5. Mitochondria and S100 preparation 
HL60 cells (1 x 107 cell/ml) or SH-SY5Y cells (1X106 cells/ml) were harvested by 
centrifugation at 600g. Cell pellet was washed in ice cold PBS and re-suspended in 2 ml 
MS buffer (210 mM mannitol, 70 mM sucrose, 5 mM Tris-HCl pH 7.5, 1 mM EDTA pH 
7.5) containing 1% protease inhibitor cocktail (Roche, Mannheim, Germany). Cells were 
homogenised by gentle douncing (100 strokes).  Homogenate was spun at 1,300g, in 4 0C 
for 10 minutes to pellet nuclei and unbroken cell. Heavy membrane (HM) fraction 
enriched in mitochondria was pellet by spinning the supernatant at 17,000g for 30 
minutes at 4 0C. Soluble cytosolic proteins (S100) were collected by further 
centrifugation of the cytosolic fraction at 100,000g in 4 0C for 30 minutes (TLA100.2 
rotor). Mitochondria were purified from the HM fraction by step sucrose gradients 
centrifugation as described (Spector et al., 1997a). Briefly, the heavy membrane pellet 
was re-suspended in 1 ml of MS buffer and layered on sucrose gradient, 1 M and 1.5 M 
sucrose buffer (10 mM Tris-HCl pH 7.5, 1 mM EDTA) before subjecting to 60,000g 
(SW41Ti rotor) centrifugation at 4 0C for 20 minutes. Relatively pure mitochondrial 
fraction was collected at the interface of the sucrose gradients and dissolved in dilution 





3.4.6. Trypan blue exclusion assay 
5% trypan blue staining was added to the harvested cells and left incubated at room 
temperature for 3 minutes. Cells were loaded onto clean microscopic slide and stabilised 
with coverslip. While healthy cells exclude trypan blue, only dead cells will be stained. 
Each set of experiment was repeated at least 3 times with 200 cells counted each time. 
 
3.5. Protein methodology 
3.5.1. Protein concentration determination by Bradford assay (Bio-Rad) 
Protein standard were set up by addition of 0, 2, 5, 8 and 10 µg of BSA to 1 ml of 
Bradford reagent (Bio-Rad).  Absorbances were read at 595 nm and a standard curve was 
plotted with O.D against protein concentration. Protein concentration was determined by 
adding the sample to 1 ml Bradford reagent and the concentration was read from the 
standard curve. 
 
3.5.2. Modified Bradford assay for urea lysis sample 
                                          Volume (µl) 
0.5 mg/ml ovalbumin 0 5 8 10 15 20 
2-D lysis buffer 30 25 22 20 15 10 
0.1 M HCl 10 10 10 10 10 10 
 
1 ml of the Bradford reagent (Bio-Rad) was added to each of the standards and incubated 




standard curve was drawn.  Samples were treated as described for standards and their 
protein content was determined from the standard curve.  
 
3.5.3. Western blot analysis 
SDS-loading buffer was added to protein mix followed by 5 minutes incubation in 950C 
before being subjected to SDS-polyacrylamide gels electrophoresis at 100 volts for 
approximately 90 minutes. Proteins separated were transferred onto Hybond C 
nitrocellulose filter (Amersham Pharmacia, Buckinghamshire, England) for 1 hour at 100 
volts. Membrane was blocked with 5%(w/v) non-fat skim milk or BSA in PBST (1.5 mM 
Potassiun phosphate monobasic, 2.68 mM Potassium chloride, 8 mM Sodium phosphate 
dibasic and 0.1% tween-20) or TBST (20 mM Tris base, 138 mM NaCl and 0.1% tween-
20) for 1 hour at room temperature with gentle agitation. Subsequently, primary antibody 
was added to the blocking solution at working dilution. Appropriate horseradish 
peroxidase-linked secondary antibodies (Bio-Rad, Hercules, CA) were followed by 
enhanced chemiluminescence detection (Pierce, Rockford, IL).  
 
3.5.4. Two-dimensional gel electrophoresis (2-D) and mass spectrometry  
Purified mitochondria were dissolved in 2 volumes of urea lysis buffer [9 M urea, 4% 3-
[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate (CHAPS), 40 mM Tris-
HCL pH 9.5, 50 mM dithiothreitol] containing 1% protease inhibitor cocktail, sonicated 
and spun at 17,000g for 30 minutes. The mitochondrial protein concentration was 
determined using the modified Bradford assay. To 100 µg of protein, 1.4 µl of 0.5 M 




mixture was topped to 350 µl with sample buffer (8 M urea, 2% CHAPS and trace 
Bromophenol blue) and laid evenly on strip holder. The plastic cover on the pH gel strip 
was removed and submerged, facing downward, into the strip holder with sample. The 
strip was further layered with 2 ml IPG cover fluid before loading onto the IPGphor 
isoelectric focusing unit (Amersham Pharmacia, Buckinghamshire, England). The sample 
was subjected to isoelectric focusing using 18 cm Immobiline DryStrip (pH 6-11) for 
62,000 V-h. After the first dimensional separation, the strip was removed from the strip 
holder, rinsed with distill water before equilibration with equilibration buffer (50 mM 
Tris-HCl pH8.8, 6M urea, 30% glycerol, 2% SDS and trace Bromophenol blue) in the 
presence of 10 mg/ml DTT for 15 minutes. The equilibration was repeated with 
equilibration and 25 mg/ml idoacetamide. The strip was then loaded onto 12.5% SDS-
PAGE gel, sealed with 0.5% agarose in running buffer, for second dimension separation 
using Protean IIxi system (Bio-Rad). Upon completion of second dimension run, the gel 
was fixed in fixing solution (50% methanol and 5% acetic acid) for overnight at room 
temperature. The proteins separation was detected by silver staining (see 3.5.13.). 
Targeted protein spots were excised from the gel and subjected to in-gel digestion with 
trypsin to recover the peptides (Shevchenko et al., 1996). Peptide sequence tags were 
generated from selected peptides by nanoelectrospray tandem mass spectrometry using a 
quadrupole-time-of-flight hybrid instrument (QSTAR; PE Sciex). The identity of the 
proteins was revealed by searching sequence databases with a combination of the peptide 
sequence tags and the mass information (Wilm et al., 1996). Peptide digestion and 





3.5.5. Production and purification of 6-Histidine-tagged recombinant 
proteins 
4 litres of bacterial clone, BL21(DE3), electrophorated with pET plasmid DNA were 
cultured in liquid broth with selection antibiotic. Cells were spun for 20 minutes at 4000 
rpm after overnight culture. Bacterial pellet was re-suspended in 5 volumn of Buffer A 
(20 mM HEPES-KOH, pH7.5, 10 mM KCl, 1.5 mM MgCl2, 1 mM EGTA, 1 mM EDTA, 
1 mM DTT, 1 mM PMSF) before subjecting lysis by sonication. Bacterial lysate 
containing soluble recombinant protein was separated from cell debris and unbroken cells 
by centrifugation at 12 000 rpm for 45 minutes in 40C (SS 34 rotor). Supernatant 
containing soluble recombinant proteins were loaded into 1 ml nickel beads in self-made 
column equilibrated with buffer A previously. Supernantant loaded in the column was 
allowed to flow through the column by gravity. Column was washed with 2 column of 
buffer A followed by single column of buffer B (1 M NaCl, 10 mM imidazole in Buffer 
A) and repeated wash with 2 columns of buffer A before performing step-wise elution 
with 6 X 500 ul of elution buffer (250 mM imidazole in buffer A). 6 fractions of protein 
were collected and ran on SDS-PAGE gels. This was followed by commassie blue stain 
to ensure protein purity. 
 
3.5.6. In vitro transcription and translation of protein 
pET plasmid DNA with T7 promoter were translated using TNT® T7 Coupled 
Reticulocyte Lysate system (Promega) according to the manufacturer ‘s instruction. 





TNT® Lysate        25 µl 
TNT®  Reaction buffer        2 µl 
TNT®  RNA polymerase        1 µl  
Amino acid mixture, minus Methionine, 1mM     1 µl   
[35S] methionine (10mCi/ml)        2 µl 
RNasin® Ribonuclease inhibitor (40 units/µl)     1 µl 
DNA template           2 µg 
Nuclease-free water       to final volume of 50 µl 
The translation reaction was incubated at 300C for 90 minutes. 35S labelled proteins were 
purified as His-tagged protein (see 3.5.5.) using 100 µl nickel column. Results of 
translation were analysed by SDS-PAGE followed by exposure to phosphoimaging plate 
for 1 hour and visualised with the phosphoimager. 
 
3.5.7. Caspase cleavage assay 
3 µl of 35S-labelled caspases was incubated with 50 µg of MCF-7 or HeLa cell lysate 
with or without 1-2 µg rat recombinant calpain II, in the presence of various 
concentration of CaCl2 (0.5, 1, or 3 mM). Protease inhibitors, caspase inhibitors and 
calpain inhibitors were added to the reaction mix when stated. The reaction mix was 
made up to a final volume of 30 µl with assay buffer (20 mM HEPES-KOH, pH7.5, 50 
mM KCl, 2 mM MgCl2, 1 mM EGTA, 1 mM EDTA, 1 mM DTT, 1 mM PMSF) and 
incubated at 370C for 1 hour. Reaction was terminated by the addition of 7 µl 4X SDS-




nitrocellulose filter (Amersham Pharmacia, Buckinghamshire, England) followed by 
exposure to phosphoimaging plate for 1 hour and visualised with the phosphoimager. 
 
3.5.8. Proteinase K digestion  
Purified mitochondria (50 µg) were re-suspended in MS buffer (without protease 
inhibitors) and incubated with 10 ng/ml Proteinase K for 10 minutes, on ice. The reaction 
mixture was spun at 17,000g for 15 minutes and pellet was collected and dissolved in 
SDS lysis buffer (2% SDS) for western blotting (Gonzalez-Baro et al., 2001).   
 
3.5.9. Alkaline phosphatase assay  
S100 proteins (20 µg from untreated SH-SY5Y cells) were incubated with 20 Units calf 
intestinal alkaline phosphatase (Promega, Manheim, Germany) at 37 0C for 30 minutes to 
dephosphorylate cytosolic proteins(Motyka et al., 2000). Reaction was stopped by the 
addition of SDS lysis buffer. 
 
3.5.10. Indirect Immunofluorescent labelling 
COS-7 or SH-SY5Y cells seeded on 12 mm coverslips were loaded with 50 nM 
MitoTracker Red CMXRos (Molecular Probes) for 1 hour and washed twice with DMEM 
before treatment. After desired period of treatment, cells were washed once in PBS and 
fixed in 4% paraformaldehyde followed by permeabilising in 0.1% Triton X-100. 
Immunostaining was performed by covering the cells with diluted antibodies (0.1% BSA 
in PBS) either 2 hours at room temperature or overnight at 40C. Subsequently, cells were 




appropriate secondary antibodies conjugated with either Alexa Fluor 488 or Alexa Fluor 
568 for 1 hour. Actin was stained by the addition of 0.05% phalloidin conjugated to 
BODIPY 558/568 (Molecular Probe) for 30 minutes in dark at room temperature. Nuclei 
were counterstained with 250 ng/ml H-33342 (Molecular Probes). Fluorescent images 
were collected and analysed using either the MRC-1024 MP laser-scanning confocal 
microscope (Bio-Rad) or a microscope equipped with an AxioCam CCD camera (Carl 
Zeiss, Oberkochen, Germany).  
 
3.5.11. Transient transfection 
Transient transfections using LipofectamineTM 2000 (Invitrogen, San Diego, CA) were 
performed following the manufacturer’s instructions. Briefly, 6 x 104 SH-SY5Y or COS-
7 cells per well were seeded on 24-well plates overnight before transfection. 0.4 µg 
plasmid DNA was diluted in 50 µl of opti-MEM® I Reduced Serum Medium and mixed 
gently. 0.5 µl of LipofectamineTM 2000 was also diluted in 50 µl of opti-MEM®. Both 
mixtures were left at room temperature for 5 minutes before combining the diluted DNA 
to the diluted liposome. The final mix was incubated for additional 20 minutes before 
loading to the plated cells incubated with 400 µl of complete medium. The liposome –
DNA mix was left incubating with cells for 8 to 24 hours depending on time course of 
transgene expression. 
 
3.5.12. siRNA transfection 
The siRNA sequence targeting of cofilin (NM_005507) was designed from position 




two nucleotides mutation (C71G and A73U) were introduced on the siRNA sequence 
used for cofilin silencing. 1 x 104 SH-SY5Y cells per well were seeded in 24-well plates 
overnight. Cells were transfected with 0.8 µg siRNAs for 72 hours using Oligofectamine 
(Invitrogen, San Diego, CA), according to manufacturer‘s instructions. By 
immunofluorescence analysis, we determined that cofilin knock-down efficiency is 
approximately 40% in SH-SY5Y cells. 
 
3.5.13. Silver staining 
Gels were washed in milli-Q water for 60 minutes with 2 changes of fresh water. This 
was followed by incubation with 0.02% sodium thiosulphate for 3 minutes. The gel was 
gently rinsed with milli-Q water before incubation with 0.1% silver nitrate for 20 
minutes. Gels were rinsed with milli-Q water. Protein spots were developed by addition 
of developing solution (188 mM sodium carbonate and 0.04% formaldehyde). The 
reaction was stopped, upon the visualisation of protein spots, with 5% acetic acid after 
the removal of developing solution.   
 
3.5.14. Viability assay 
Viability of cells was accessed using the cell proliferation reagent WST-1 (Roche 
Diagnostics, Germany) according to the manufacturer’s instruction. Briefly, SH-SY5Y 
cells transfected with cofilin or control siRNA were treated with 1 µM STS for 6 hours or 
100 µM etoposide for 10 hours, respectively. The percentage of viable cells was 
quantified by their WST-1-reducing capacity after incubation with WST-1 (1:10 dilution) 




treated cells was expressed as percentage of formazan absorbance (A460 nm-A690 nm) 
compared with that of control cells. 
 
3.5.15. Clonogenicity assay 
The clonogenicity assay was performed as described (Chen et al., 2001). Briefly, SH-
SY5Y cells transfected with cofilin and control siRNA were treated with 1 µM STS for 6 
hours. Cells were trypsinised and plated onto 96 well round bottom plate with a density 
of 1 cell/well by serial dilution method. Cell colonies were counted 8 days after plating 
and the percentage of clonogenic cells was calculated by the ratio of the theoretical 
Poisson density of the number of negative wells observed, against the initial plating 
density using the equation: % clonogenicity = (Ln × [96/negative wells])/(plate 
density) × 100, where negative wells is the number of wells that failed to grow colonies 
and plate density is the original cell plating density per well. 
 
3.5.16. Isolation of mitochondria and the in vitro assay of cytochrome c 
release 
Mitochondria (15 µg, 0.5 mg/ml) were isolated from SH-SY5Y cells. The procedures for 
the isolation of mitochondria and the cytochrome c release assay were essentially 
performed as previously described (Chan et al., 2003). Briefly, cells were suspended in 
isolation buffer (320 mM sucrose, 1 mM EDTA, 50 mM HEPES pH 7.5 and 1 mM DTT) 
and disrupted by 10 expulsions through a 27-gauge needle. Disrupted cells were 
centrifuged two times at 1,000g for 5 minutes to remove cell debris and nuclei. The 




were re-suspended in assay buffer (250 mM sucrose, 2 mM KH2PO4, 5 mM sodium 
succinate, 2 mM EGTA and 10 mM HEPES pH 7.5) at 0.5 mg/ml and treated at 300C 
with the indicated proteins for 30 minutes followed by centrifugation at 10,000g for 10 
minutes. Proteins from mitochondrial pellets and supernatant fractions were separated by 


















Chapter 4: Result I 
Direct regulation of caspases by calcium/calpain 
 
Caspases play an important role in the progression of the apoptosis process. Once 
activated, caspases trigger a chain of substrate proteolysis that results in the dismantling 
of the apoptotic cell. Our interest in the understanding of the regulation during apoptosis 
led us to investigate whether caspases are influenced by an increase in intracellular 
calcium and subsequently activation of calpains. To dissect the role of calcium in 
apoptosis, we set up an in vitro biochemical assay to address the question of whether a 
direct relationship between calcium and caspases exists.  
 
Using radiolabelled caspases as substrate, we screened for the presence of cytosolic 
factor(s) that act on the caspases in the presence of calcium.  Caspase –7, -8 and –9 
cloned into pET vector (generous gift from Wang X.D. laboratory) were in vitro 
translated using TNT® T7 Coupled Reticulocyte Lysate system (Promega). The His-
tagged-35S proteins were purified using a 100 µl Nickel beads column and used as 










4.1. Cleavage of caspase-7 by MCF-7 cytosolic factors in the presence of 
calcium 
To identify factor(s) involved in calcium-mediated apoptosis, we used in vitro translated 
35S- caspase-7 as substrate. The proteins were incubated with 30 µg MCF-7 cell lysate in 
the presence of increasing calcium (fig 4.1.A). Caspase-7 was cleaved in the presence of 
1 mM calcium (fig 4.1.A, lane 5), however, the cleaved fragments generated were 
different from that in the presence of apoptotic inducers, dATP and cytochrome c (fig 
4.1.A, lane 2). Caspase-7 was cleaved to yield characteristic P20 and P10 fragments 
(indicated by asterisks) by endogenouse caspase-9 that was activated by dATP and 
cytochrome c. The differences in the cleavage profile led us to postulate that the 
proteolysis of caspase-7 by calcium-dependent factors results in inactive caspase-7.  
 
We further characterised the calcium dependent factor(s) that contributed to caspase-7 
cleavage by using different protease inhibitors to block the proteolysis process (fig 4.1.B, 
C).  Interesting, we found that only cysteine protease inhibitors such as leupeptin and E64 
could prevent caspase-7 proteolysis (fig 4.1.B, lane 3 & 6). The addition of 20 µM 
caspase inhibitors (fig 4.1.C) eliminated the possible involvement of other caspases.  
However, pre-incubation with 100 µM DEVD was able to block caspase-7 cleavage. This 
was consistent with other reports stating that inhibition of other cysteine proteases than 
caspases is observed with high concentration of caspase inhibitors (Cryns and Yuan, 
1998). Taken together, the data suggest that cysteine proteases, other than caspases, are 





Figure 4.1. Cleavage of caspase-7 by cysteine protease in the presence of calcium. 3 µl in vitro 
translated and 35S-labelled caspase-7 by TNT® T7 Coupled Reticulocyte Lysate system, was incubated 
with 50 µg MCF-7 lysate and calcium or 1 mM dATP with 0.2 µg cyt c, for 1hour at 370C. Reaction was 
stopped with SDS-lysis buffer and mixtures were subjected to 15% SDS-polyacrylamide gel 
electrophoresis. Gels were dried and visualised by phosphoimager. (A) 35S-caspase-7 was cleaved by 
cytosolic factor(s) when incubated with increasing calcium.  Lane 2 showed the generation of apoptotic 
fragments, P20 and P10, of caspase-7 in the presence of dATP/cyt c, indicated by asterisks. (B) & (C) 35S-
caspase-7 in the presence of 3 mM calcium was co-incubated with 5 µM of leupeptin, E64, aprotinin and 
pepstatin or 20 or 100 µM caspase inhibitors. Caspase-7 cleavage was inhibited by cysteine proteases and 











4.2. Cleavage of caspase-7 by rat recombinant calpain II 
Next, we tested the direct involvement of calcium-activated cysteine protease, calpain, in 
the proteolysis of caspase-7 by using calpain inhibitors (fig 4.2.A). Indeed, both calpain 
inhibitor I and II are able to protect caspase-7 from proteolysis. More interesting, calpain 
inhibitor II displayed full inhibition at as low as 5 µM concentration (fig 4.2.A, lane 6). 
 
To further confirm the direct role of calpain II in caspase-7 cleavage, we reconstructed 
the assay, replacing the lysate with recombinant His-tagged rat recombinant calpain II 
protein, a generous gift from Dr. John Elce (fig 4.2.B).  Indeed, incubation of caspase-7 
with 1 µg of recombinant calpain and 0.5 µM calcium resulted in similar caspase–7 
cleavages profile as the cytosolic factor. Our data demonstrate that calpain II is 
responsible for caspase-7 cleavage in the presence of calcium. 
 
4.3. Cleavage of caspase-8 and –9 by calpain II 
In order to determine if calpain’s effect on caspase-7 is restricted to the downstream 
caspases, we repeated the biochemical assay on the upstream caspases, both caspase-8 
and –9. Interesting, upon incubation with calcium with either lysate or recombinant 
calpain II, caspase-8 and –9 were cleaved into 3 and 4 fragments, respectively (fig 4.3.A, 
lane 2, 3). Similar inhibition profiles were observed when the assay mix was pre-
incubated with calpain inhibitors and cysteine protease inhibitors (leupeptin and E64). 
 
To map the cleavage sites on caspase-9 by calpain, we co-incubated enzymatic-dead 





Figure 4.2. Direct cleavage of caspase-7 by rat recombinant calpain II. (A) 35S-caspase-7 was co-
incubated with 50 µg MCF-7 lysate, 3 mM calcium and various concentration of calpain inihibitor I and II 
at 370C for 1hour. (B) 3 µl of 35S-caspase-7 was co-incubated with 1 or 2 µg of recombinant rat calpain II 
(kind gift of Dr Elce) and various concentration of calcium under the same assay condition.   
 
mM calcium. The four caspase-9 fragments of 37, 35, 25 and 15 kDa generated by 
calpain (fig 4.3.B, lane 5) were excised from the blot after staining with 0.1% amido-
black in 10 % acetic acid. The staining solution was removed by continuous washing 
with distilled water before submission for N-terminal/Edman protein sequencing.  As 
expected, we did not obtain any sequence information from either the full length or the 
C1 (37 kDa) fragments of caspase-9. This was probably due to the modification at the N-
terminal of the protein. Analysis of C2 (35 kDa), C3 (25 kDa) and C4 (15 kDa) fragments 
yielded 10 amino acid sequences as shown on the right panel of fig 4.3.B. By mapping 
these N-terminal sequences of the 3 fragments, we located 2 calpain-cleavage sites on 








Figure 4.3. Calpain cleaves both caspase-8 and –9.  (A) 35S-caspase-8 and –9 were cleaved by calcium 
activated factor in the lysate and recombinant calpain II into 3 and 4 fragments, respectively. Proteolysis of 
both caspases was prevented by various inhibitors.  (B) Mapping of calpain cleavage sites on recombinant 
caspase-9. Left panel shows the Western blot analysis of calpain cleavage of recombinant caspase-9 
(C287A) using rabbit anti-caspase-9 antibodies. 0.5 µg active caspase-3 (lane 2), 0.5 µg of calpain II with 3 
mM calcium (lane 5) were used in the reactions. Right panel shows the schematic diagram of the calpain 
cleavage sites on caspase-9 (arrows on top) and the corresponding cleavage products. Residue134 represent 
the end of the prodomain. Cys287, Asp315 and Asp330 represent the enzymatic active site, caspase-9 self-
cleavage site and caspase-3 cleavage site, respectively. Peptide sequences for C2, C3 and C4 were shown 
on the left side of the products. N-terminal of C1 is blocked for sequencing. (C) Calpain cleavage of 












residue 115. The cleavage at residue 115 resulted in an N-terminal truncated caspase-9. 
The loss of CARD domain may render caspase-9 unable to bind to Apaf-1.  Interestingly, 
the second cleavage site, residue 330, at the C-terminal half of the protein, is also a 
caspase-3 target site on caspase-9. This is consistent with the size of C1 fragment, which 
is exactly the same size as caspase-3 generated fragment (fig 4.3.B, left panel, lane 2). 
Unlike the cleavage at residue 115, calpain cleavage of caspase-9 at the residue 330 may 
result in an active caspase-9.  
 
Further cleavage assay on point-mutants of caspase-9 showed that calpain cleavage on 
caspase-9, unlike caspases, is not dependant on the aspartic acid (fig 4.3.C, lane 5,7) 
residue at the P1 position and is independent of caspase-9 enzymatic activity (fig 4.3.C, 
lane 9). Our data demonstrate that calpain cleaves both caspase-8 and -9 in the presence 
of calcium. Unlike caspases, calpain cleavage on caspase-9 may or may not result in 
active caspase-9 and the cleavage sites are not dependent on the presence of aspartic acid 
on the P1 position.  
 
 
4.4. Calpain proteolysis renders caspase-9 inactive  
Next, we evaluated whether cleavage of caspase-9 by calpain results in an active enzyme. 
Here, we utilised radiolabelled caspase-3 as caspase-9 substrate. As a positive control, we 
incubated the lysate with dATP/cyt c (fig 4.4. top panel, lane 2). The presence of 
dATP/cyt c activated the endogenous caspase-9, which in turn cleaved caspase-3 to 








Fig 4.4.  Cleavage of caspase-9 by calpain renders it incapable of caspase-3 activation. HeLa cell 
lysates were incubated with 1, 2 and 5 µg of recombinant calpain II at 370C for 1 hour. 35S-caspase-3 
cleavage was monitored in these conditions. Lane 2 shows caspase-3 cleavage in the presence of dATP and 
cyt c, as a positive control. The same filter was probed with rabbit anti-caspase-9 antibody to show caspase-
9 cleavage in the presence of recombinant calpain II and calcium. 
 
Concomitantly, re-probing the blot with anti-caspase-9 antibodies showed that the 
upstream caspase was indeed cleaved (fig 4.4, lower panel, lane 2). As we activated 
calpain by the addition of calcium (fig 4.4, lower panel, lane 5-7), caspase-9 processing 
was observed in the Western blot. Interestingly, our results showed that there are no 
caspase-3 proteolysis under this condition (fig 4.4. top panel, lane 5-7). Our data 
demonstrate that cleavage of caspase-9 by calpain render the enzyme incapable of 







4.5. Truncated caspase-9 inhibits dATP/cyt c induced caspase-9 and –3 
activation  
Since caspase-9 when cleaved by calpain was inactive in the processing of caspase-3, we 
next investigated whether calpain cleavage of caspase-9 has an effect on the dATP/cyt c 
pathway. Here, we pre-treated cell lysate with calcium and various amounts of 
recombinant calpain II to activate cleavage of the endogenous caspase-9. Subsequently, 
we triggered caspase-3 processing by adding dATP and cytochrome c to the mixture. Our 
data showed that increasing amount of recombinant calpain not only cleaved caspase-9 as 
showed in the Western analysis (fig 4.5, lower panel, lane 5-7), it also prevented 
caspase-3 activation in the presence of dATP and cytochrome c (fig 4.5, top panel, lane 
7). This inhibition was relieved by the incubation with calpain inhibitor II (fig 4.5, top 
panel, lane 8). Taken together, calpain cleavage of caspase-9 not only resulted in an 
inactive protein. Cleavage by calpain also inhibited the activation of dATP/cyt c pathway. 
 
4.6. Activated calpain cleaves endogenous caspases 
In order to show that calpain cleaves caspases in intact cells in vivo, we exposed SH-
SY5Y cells to high calcium concentrations in the medium and the calcium ionophore 
A23187 to promote uptake of calcium into the cells. Western blot analysis of these 






Figure 4.5. Cleavge of caspase-9 by calpain blocked dATP and cyt c induced caspase-3 cleavage. 
Cleavage of 35S-caspase-3 was blocked when cell lysates were pre-incubated with recombinant calpain II in 
the presence of 3 mM calcium. The same filter was probed with rabbit anti-caspase-9 antibody to monitor 
caspase-9 cleavage by calpain. 
 
autolysis and activation of the small calpain subunit (fig 4.6A). Activation of calpain 
after 5 minutes of calcium ionophore treatment (fig. 4.6.A lane 4) led to both caspase-7 
and –9 cleavages as similar or slightly later time point (fig 4.4 B and C, lane 4 & 5). The 
proteolysis of caspases can be blocked by pre-treatment with calpain inhibitor II (fig 4.4, 
lane 7) but not with caspase inhibitor (fig 4.4, lane 8). Our data demonstrate that 






Figure 4.6. Time course of calpain activation and caspase-7 and –9 cleavages in SH-SY5Y cells after 
calcium ionophore treatment. (A) Western blot analysis showing calpain activation was measured by the 
autolysis of calpain’s 30 kDa small subunit. (B) (C) The same blot was probed with anti-caspase-7 and –9 
antibodies respectively, to show the cleavage of both caspases in the presence of A23187. 5 µM calpain 
inhibitor II and 20 µM z-VAD were pre-incubated with the cells before A23187 treatment shown in lane 7 
and 8.  
 
 
4.7. Pulsing of SH-SY5Y cells with calcium protects cells from H7-
induced apoptosis 
In order to demonstrate the inhibitory role of calpain in apoptosis, we treated SH-SY5Y 
cells with the kinase inhibitor H7 and activated endogenous calpains. The apoptotic 
stimulus H7 leads to caspase-3 dependent apoptosis in SH-SY5Y. We treated the cells for 
the duration of 24 hours with H7 and additionally repeated exposure of A23187 and high 
calcium concentration in the medium for 30 minutes every 8 hours to ensure that the 
calpain activation and caspase-9 cleavage by calpain were sustained. As shown in the 
death curve (fig 4.7), H7-treated cells without calcium pulsing underwent massive cell 




hand, SH-SY5Y pulsed with calcium was partially protected from H7-induced apoptosis. 
Exposure of A23187 and high calcium concentration in the medium alone did not trigger 
cell death. Our data demonstrate that the activation of calpain can indeed prevent 
caspase-3 dependent apoptosis in cells.  
















Figure 4.7. Periodically calcium pulsing protects SH-SY5Y cells from H7-induced cell death.  SH-
SY5Y cells were treated with 100 µM H7 over a period of 24 hours. 3 µM A23187 and 250 mM calcium 
were added to the cells every 8 hourly for a period of 30 minutes. Cells were harvested and trypan blue 
exclusion assay was performed. Cells stained blue were scored as dead cells. Data presented are means ± 






















We report here the identification of a negative regulation of caspases by calpain. Calpain 
cleaved procaspase –7, -8 and -9 in the presence of calcium. The proteolysis resulted in 
truncated and inactive caspase-9, unable to activate procaspase-3 nor respond to Apaf-
1/dATP/cyt c pathway. In vivo in SH-SY5Y cells, calpain activation blocked the caspase 
cascade. Pulsing of SH-SY5Y cells with periodical high level of calcium resulted in 
calpain activation and inhibition of caspase-3-dependent apoptosis by proteolytic 
inhibition of caspase-9 and –7. 
 
Caspases and calpains share some of their substrates and both have been shown to be 
active during apoptosis. The role of calpain in apoptosis has been studied by various 
groups using different cell lines. In the 1990s, both Zhivotovsky and Squier (Squier and 
Cohen, 1997; Zhivotovsky et al., 1994) have shown that by chelating extracellular 
calcium, thymocytes are protected from apoptosis induced by glucocorticoids. Recently, 
the calcium-activated protease was shown to cleave Bcl-2 and Bcl-xL at their N-terminal 
resulting in the relief of Bcl-2 pro-apoptotic proteins (such as Bax) activity, to trigger 
cytochrome c release from mitochondria in ionomycin treated LCLC 103H cells, human 
lung carcinoma (Gil-Parrado et al., 2002). Calpain also acts directly on Bid and Bax, 
resulting in their proteolysis, enhancing the mitochondria translocation of these 
proapoptotic proteins to mediate cytochrome c release in melanoma and 293 cells, 





Calpain’s indirect role in mediating the release of cytochrome c, results in activation of 
caspase-9 and caspase-3. These events indicate calpain’s activity is upstream of caspase 
cascade in these cell models. Its pro-apoptotic role is also demonstrated in the 
degradation of XIAPs that inhibit caspase-3 activity during TNF and Fas death induction 
on the neutrophils (Kobayashi et al., 2002). The importance of XIAP degradation by 
calpain is further illustrated in chronic neutrophilic leukemia where there is a presence of 
excessive neutrophils with decreased calpain activity and XIAP degradation (Kobayashi 
et al., 2002). 
 
Intriguingly, using our in vitro assay and different cell lines, we and others demonstrated 
that calpain can negatively regulate caspase activation as well (Chua et al., 2000; Wolf et 
al., 1999).  
 
Activation of calpains inhibit caspase-dependent cell death 
We showed that calpain II or m-calpain, a calpain family member activated by millimolar 
concentration of calcium, cleaves procaspase-7. The cleavage, however, did not generate 
characteristic P20 and P10 fragments, which represent its active form, but yielded two 
inactive fragments. The proteolysis activity of calpain I and II also resulted in cleavage of 
procaspase-9 (Wolf et al., 1999) and both procaspase-8 and –9 (Chua et al., 2000), 
respectively. We showed that calpain II cleaved procaspase-9 at the residue 115 and 330. 
The C-terminal calpain cleavage site D330, coincides with the caspase-3 proteolytic site, 
utilised during the apoptotic feedback pathway (diagram 3). Cleavage at this position by 




proteolytic activity that amplifies the caspase cascade. Interestingly, calpain proteolysis 
of procaspase-9 did not result in its activation as shown by the absence of caspase-3 
cleaved fragments in the assay. These data suggest cleavage of procaspase-9 at the 
appropriate position, may not lead to the activation of caspase-9, in agreement with 
previous observations (Stennicke et al., 1999). In addition, it is not surprising when 
another regulatory system exists that prevents untimely activation of caspases 
intracellularly. XIAP interactions and degradation of active caspase –7 and –3 is an 
example (Roy et al., 1997). Therefore, calpain interaction with caspase-7 and –9 render 
both proteolytically inactive. 
 
In order to activate the effector caspases, the concentration of procaspases at the DISC or 
apoptosome is important for self-activation. For the latter, dATP and cytochrome c 
together with Apaf-1 are necessary (Li et al., 1997). In our assay, we are unable to 
reconstitute the caspase-3 activation when co-incubated caspase-9 with dATP/cyt c and 
Apaf-1 in the presence of rat recombinant calpain II. Thus, calpain cleavage generates 
inactive caspase-9 that is unable to induce caspase-3 activation in vitro. This inhibition 
strongly indicates that cleavage by calpain on procaspase-9 occurs at the prodomain 
instead of D330 is predominant. The prodomain, that contained the CARD, is crucial for 
caspase-9 interaction with Apaf-1 to form the apoptosome. Loss of prodomain by calpain 
cleavage thus results in enzymatic incompetent caspase-9 that cannot be activated and is 
unable to activate downstream effector caspase.  Although our data showed that activated 
calpain cleaves caspase-9, we however, did not demonstrate the cleavage of caspase-3 by 




As reported by Wolf et al., calpain cleaves caspase-3 at the N-terminal to generate a 
fragment of 30 kDa (Wolf et al., 1999). And since the full-length caspase-3 is 32 kDa, it 
is likely the SDS-PAGE gel did not resolve the two fragments. Another possibility shown 
by Lankiewicz et al. is that only limited proteolysis procaspase –3 was observed and it is 
likely that calpain do not have high affinity for this caspase compared to the upstream 
caspases (Lankiewicz et al., 2000). 
 
Concomitant with calpain cleavage of caspases, calcium pulsing of SH-SY5Y cells 
treated with apoptotic stimulus H7, resulted in constant activation of calpain and calpain-
mediated caspase-7 and –9 cleavages.  The resistence of these pulsed cells against H7-
induced apoptosis, strongly supported the protective role of calpain against caspase-
dependent cell death. In our in vivo system, calpain activation prevents apoptosis.  
 
Interestingly, although calpain was shown to cleave caspases and render them inactive, 
there is however the presence of apoptotic-like cell death, suggesting a caspase-
independent apoptotic death (Bizat et al., 2003; Lankiewicz et al., 2000; Wolf et al., 
1999). Phosphatidylserine externalisation, cell shrinkage and cell death that resembles 
apoptosis morphologically, were observed in cells with calpain activity and truncated 
caspase fragments. Both Lankiewic and Bizat demonstrated the caspase-independent, 
calpain-dependent cell death in neuronal system (Bizat et al., 2003; Lankiewicz et al., 





Calpains inhibit caspase-dependent apoptosis and activate caspase-
independent cell death 
Although calpain is ubiquitiously expressed, as discussed, its activity and role in 
apoptosis differ in different cell types. Distinctively, calpain inhibition of caspase 
activities by proteolysis maybe involved in the neuronal excitotoxicity cell death. 
Glutamate receptor overactivation has been implicated as the main factor that contributed 
to neuronal cell death after trauma, stroke and epileptic seizures (Choi, 1994). Excessive 
calcium uptake by the neuronal cells is observed in the overstimulation of the receptor 
(White and Reynolds, 1995) and in the presence of sufficient ATP, and it was proposed 
that the neurons will undergo apoptosis instead of necrosis (Volbracht et al., 1999). 
Recently, using rat hippocampal neurons exposed to NMDA (N-Methyl-D-aspartate) to 
mimick the excessive stimulation of the glutamate receptor, Lankiewicz et al. have 
shown that neurons undergoing excitotoxic apoptosis with caplain I activation and 
cytochrome c release from mitochondria. Intriguingly, no caspase activity was detected. 
Caspase-3 activity was detected only in the presence of calpain inhibitor indicative of 
calpain inhibition on caspase activity, supporting our in vitro data that calpain inhibits 
caspase-9/caspase-3 pathway.  
 
Another group by Bizat et al. demonstrated the calpain-dependent cell death in vivo 
disease model. A rat model of Huntington disease treated with mitochondrial toxin 3-
nitropropionic acid (3-NP) was used to induce neurodegeneration and cell death of the 
striatal neurons (Bizat et al., 2003). Interaction between the calpain and caspases were 




caspase-9 via proteolysis. Interestingly, they also showed that calpain cleaved activated 
caspase-3’s P20 residues at the C-terminal ends (Bizat et al., 2003). In both neuronal 
models, calpain activation switches the caspase-dependent apoptotic pathway to 
independent apoptosis, demonstrating the negative regulation of caspase by calpain in the 
neuronal system. 
 
Role of calpain and its negative regulation of caspases 
We propose that activated calpains cleave and prevent caspase activation. This protective 
role of calpain may exist in the neuronal system, which is exposed periodically to high 
calcium. Calcium is a highly versatile intracellular signal that regulates many cellular 
functions such as contraction, exocytosis, transcription, and metabolism (Berridge et al., 
2000). Neuronal cells such as central neuron and cerebellar granule neurons are 
constantly exposed to high calcium in the event of glutamate receptor-mediated synaptic 
transmission and activation that is required for the development, differentiation, and 
survival (Moran and Patel, 1989). Thus, the activation of calpain upon physiological 
activation of the glutamate receptors may protect and prevent premature neuronal cell 
death. On the other hand, constantly high level of calcium has an adverse effect on 
cellular function. The use of calcium ionphores such as ionomysin and A23187, and 
calcium ATPase inhibitor thapsigargin, dramatically increase the intracellular calcium 
level, and by this calcium overload leading to cell death (Rami et al., 2000; Squier and 





In cellular model of excitotoxic apoptosis, this negative regulation of caspases by 
calpains result in an alternative form of apoptosis - caspase-independent, calpain- 






















Conclusions and future perspective 
 
This work is one of the first two reports that demonstrate the cross talk between the two 
families of cysteine proteases, the calpain and caspases. Caspases play a major role in the 
morphological and biochemical changes during apoptosis. It is regulated by several 
mechanisms such as proteolysis, phosphorylation, and interaction with the endogenous 
inhibitors IAPs. Our research identified calpain, in the presence of elevated calcium, 
negatively regulated caspase –7 and –9 via proteolysis. This negative regulation of 
caspases by calpain may serve to prevent apoptosis induction in tissue such as neurons 
that are exposed to high calcium. Synaptic transmission through the glutamate receptors 
results in calcium uptake into the post-synaptic neurons. Calpain activation and 
proteolysis of caspases may prevent premature neuronal death by inhibiting caspase-
dependent apoptosis. However, the cleavage of caspases by calpain may also result in an 
alternative form of cell death: caspase independent, but calpain mediated apoptosis.  
 
Although the negative regulation of caspase –3, -7 and –9 by calpain are well established 
in recent years, the calpain-dependent and caspase-independent apoptosis, however, 
awaits further characterisation. To date, the effect of calpain is mainly observed in the 
intrinsic pathway. The study on the effect of this protease on caspase-8, which was shown 
to be cleaved as well, will thus provide an insight on calpain and the death receptor 





Chapter 5: Result II 
Mitochondrial translocation of cofilin induce apoptosis via the 
intrinsic pathway 
 
To study the upstream apoptotic signal transduction prior to mitochondria release of the 
apoptogenic factors, we set up comparative display of mitochondrial proteomes at the 
early stage of staurosporine-induced apoposis to screen for protein(s) that translocates 
in/out of the organelle or mitochondrial protein that undergoes modification during the 
process of apoptosis. 
 
5.1. Cofilin translocation into mitochondria in early stage of apoptosis  
Intrigued by the fact that protein movement in or out of the mitochondria is essential to 
regulate apoptosis, we harvested mitochondria from staurosporine (STS)-treated and 
untreated HL60 cells and investigated their mitochondrial protein compositions using two 
dimensional gel electrophoresis (2-D) visualised after silver staining. STS is a general 
kinase inhibitor that triggered apoptosis in a time-dependent manner (fig 5.1.1.). 
Apoptosis induced by STS can be inhibited when co-incubated with zVAD-fmk, a 













Figure 5.1.1. STS-induced caspase-dependent apoptosis on HL60 cells in a time-dependent manner. 1 
X 107 cells/ml HL60 cells were treated with 1 µM STS. At specified time point, cells were harvested and 
nuclei were stained with 250 ng/ml H-33342 for 10 minutes. Apoptosis was scored according to the nuclei 
morphology. Data presented are means ± SD values from three independent experiments with 300 cells 
counted.  
 
To study the apoptotic event at the early phase of apoptosis, we compared the 
mitochondrial proteomes of control, 1 hour and 2 hours STS treated cells, when majority 
of the cells were at early phase of apoptosis. A total of ~700 protein spots were observed 
in two pH ranges first-dimensional isoelectric separation (fig. 5.1.2.A and B). We 
observed a significant different in the profile of 4 distinct protein spots in mitochondrial 
fractions from STS-treated apoptotic cells compared to untreated controls. Using mass 
spectrometric analysis, we identified one of the spots as cofilin, a 19 kDa actin-binding 

































Figure 5.1.2. Identification of cofilin in mitochondrial fractions from STS-treated cells by 2-D PAGE 
analysis. Proteins from gradient purified mitochondria isolated from HL60 cells treated with 1 µM STS 
were resolved by 2-D PAGE before visualised by silver staining. (A) 3 protein spots with different profile 
after STS treatments were observed for isoelectric focusing pH 3-10. (B) 1 protein spot was indentified 
with change in profile on isoelectric focusing pH 6-11. Arrow indicates the protein spot #4 as 19 kDa and 
pI 8-8.5 cofilin, identified by mass spectrometry analysis. 
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Of the 4 protein spots identified, we found cofilin, the non-mitochondrial protein, 
interesting and could potentially be the early apoptotic signal transducing from the 
cytoplasm to mitochondria. To confirm the mitochondrial translocation of cofilin, both 
cytosolic and mitochondrial fractions from STS-treated HL60 cells were subjected to 
Western blot analysis. As shown in figure 5.1.4, cofilin was found exclusively in 
cytosolic, but not in mitochondrial fractions in the absence of STS. After STS treatment, 
we observed cofilin accumulation in mitochondrial fractions (fig. 5.1.4.A), and this was 
concomitant with the disappearance of cofilin from the cytosolic fractions (fig. 5.1.4.C). 
Cofilin translocation was detected as early as 5 min after STS treatment and reached 
maximum levels after 15 min (fig. 5.1.4.B). At similar time point, accumulation of Bad 
was observed (fig. 5.1.4.A & B), consistent with previous observations that Bad 
translocation into mitochondria is an early event in apoptosis (Zha et al., 1996). 
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The release of cytochrome c and activation of caspase-3 as shown by spectrin cleavage, 
occurred from two hours onwards after STS treatment, i.e. after cofilin translocation into 
mitochondria (fig. 5.1.4.C). Accordingly, cofilin translocation was not blocked by the 
broad-range caspase inhibitor, zVAD-fmk (fig. 5.1.4.A), at the concentration that 
completely inhibited STS-induced apoptosis. Cofilin translocation was not a result of 
increased association of actin with mitochondria, as similar levels of actin were detected 
in mitochondrial fractions from control as well as apoptotic cells (fig. 5.1.4.A). Cytosolic 
protein contamination in the gradient purified mitochondria was not observed as no 
cytosolic Grb2b protein was detected (fig. 5.1.4.A). Importantly, an early accumulation 
of cofilin in mitochondrial fractions was observed in different cell types (SH-SY5Y, 
COS-7, HeLa) when treated with another apoptotic stimulus etoposide (see later), 
indicating that mitochondrial translocation of cofilin is a general phenomenon occurring 
at an early stage of apoptosis prior to caspase activation. 
 
The translocation of cofilin was further examined at the sub-cellular level in SH-SY5Y 
cells using indirect immunofluorescence microscopy (fig. 5.1.5). In the absence of STS, 
cofilin showed a diffuse staining pattern in cytoplasm and nucleus, and did not display 
any co-localisation with the mitochondria marker MitoTracker Red. Detectable nuclear 
localisation of cofilin can be explained by the presence of a nuclear-localisation signal 
(30-34 aa) identified previously (Samstag et al., 1994). Upon treatment with STS in the 
presence or absence of zVAD-fmk, the cell bodies shrunk and cofilin staining in both 
nucleus and cytoplasm was dramatically diminished. A proportion of the cofilin now co-










Figure 5.1.4. Mitochondrial accumulation of 
cofilin prior to cytochrome c release. Gradient 
purified mitochondrial (A and B) and S100 fractions 
(C) from HL60 cells treated with 1 µM STS and 50 
µM zVAD-fmk were subjected to Western blot 
analysis for cofilin, Bcl-2, Bad, actin, cytochrome c 
(cyt c), spectrin and Grb2b (cytosolic marker 


















Figure 5.1.5.  Sub-cellular localisation of cofilin. SH-SY5Y cells were loaded with MitoTracker Red and 




















120 kDa caspase –3 generated fragment 













Figure 5.1.6. Apoptosis and mitochondrial translocation of cofilin induced by STS is blocked by Bcl-
xL over-expression. SH-SY5Y cells were transfected with 0.4 µg myc c-tagged Bcl-xL DNA construct for 
16 hours. (A) Bcl-xL overexpression inhibits STS-induced apoptosis. pEGFP-C3 was co-transfected and 
apoptosis scored in GFP-positive cells. Data presented are means ± SD values from three independent 
experiments with 300 GFP-positive cells counted. (B) Cofilin mitochondrial translocation is prevented by 
Bcl-xL overexpression. Cells were treated with 1 µM STS for 1 hour, fixed and stained for cofilin and myc 
c-tagged BclxL.  
Fig 5.1.5. & 5.1.6. Specimens were imaged by confocal microscopy using Normaski optics and/or 
fluorescence at similar focal planes. Image width corresponds to 40 µm. Data are representative of five 
independent experiments. 
 
    
                                                                  
 
Figure 5.1.7. Cofilin is localised to the mitochondrial  
outer membrane. Gradient purified mitochondria  
from HL60 cells were digested by proteinase K,  
before subjected to Western blot analysis for cofilin,  

































In contrast to caspase inhibitor zVAD-fmk, no obvious mitochondrial localisation of 
cofilin was observed in Bcl-xL overexpressing cells upon STS treatment. Overexpressed 
Bcl-xL showed mitochondrial localisation (fig. 5.1.6.B) and rendered SH-SY5Y cells 
resistant to apoptosis (fig. 5.1.6.A). After STS treatment for 1 hour, Bcl-xL 
overexpressing cells displayed shrinkage and slightly decreased cofilin staining in 
nucleus and cytoplasm. However, cofilin staining appears to be diffuse and was not co-
localised with Bcl-xL (fig. 5.1.6), indicating that Bcl-xL antagonises mitochondrial 
translocation of cofilin. 
 
The precise location of cofilin at the mitochondria was further determined using 
proteinase K digestion of isolated mitochondria (fig. 5.1.7.). Outer membrane proteins 
such as Bcl-2 are cleaved under this condition, whereas proteins localised at the inter-
membrane space (e.g. cytochrome c) or the inner membrane (e.g. COX-IV) are left intact. 
When mitochondria isolated from apoptotic cells were treated with proteinase K, cofilin 
was degraded, similar to Bcl-2 however, cytochrome c and COX-IV remained intact after 
proteinase K digestion. These data indicate that cofilin becomes associated with the outer 
mitochondrial membrane early in apoptosis.  
 
5.2. Silencing of cofilin by siRNA prevents cytochrome c release and 
apoptosis 
To further corroborate that mitochondrial translocation of cofilin is crucial for the 
initiation of apoptosis, we used small interfering RNA (siRNA) to silence cofilin proteins 




reduced in the presence of cofilin specific dsRNA oligomer (fig. 5.2.1.A). As control we 
used a siRNA containing two nucleotides mutation (C71G and A73U) on the cofilin 
sequence. This control siRNA did not affect cofilin protein levels (fig. 5.2.1.B). By 
immunofluorescence analysis, we determined that cofilin expression was reduced to 
undetectable levels in 40% of the cells. SH-SY5Y cells lacking cofilin were healthy and 
displayed normal morphology (fig. 5.2.1.B and fig 5.2.2.). Further analysis of cofilin 
knock-down cells showed that F-actin staining was enhanced using fluorescent 
phalloidin, a plant derivative that binds selectively to F-actin (fig. 5.2.1.B). This is 
consistent with the established function of cofilin as an actin depolymerising agent as the 
absence of cofilin renders the depolymerisation process inactive, resulting in 
accumulation of F-actin. This data further consolidated that the siRNA approach lead to 
silencing of cofilin in SH-SY5Y cells.   
 
In the presence of STS, cells with normal levels of cofilin underwent apoptosis displaying 
typical morphological changes such as diffuse cytochrome c staining in the cytoplasm, 
and nuclear condensation and fragmentation (fig. 5.2.2. arrowhead). In cofilin knock-
down cells, however, the punctuate cytochrome c staining pattern was maintained and 
cells did not display apoptotic nuclear morphology (fig. 5.2.2. arrow). These data indicate 
that cofilin plays a crucial role in the initiation of apoptosis by translocating to 
mitochondria and inducing cytochrome c release. 
 
Next, we found that silencing of cofilin protected cells from STS- or etoposide-induced 













Figure 5.2.1: Silencing of cofilin expression using cofilin siRNA. Cells were transfected with cofilin 
siRNA for 72 hours.  (A) Reduced cofilin expression in the presence of cofilin siRNA. 20 µg total cell 
lysates were subjected to Western blot analysis for cofilin and tubulin. (B) Increase F-actin staining was 
observed in cofilin knock-down cells. Cells were fixed and stained simultaneously for cofilin and F-actin 
using phalloidin. Nuclei were stained with H-33342. Arrows indicate cofilin knock-down cells and 










Figure 5.2.2. Lack of cytochrome c release and apoptotic morphology in cofilin knock-down cells. 
Cells transfected with cofilin siRNA were treated with 1 µM STS for 4 hours, fixed and stained 
simultaneously for cofilin and cyt c. Nuclei were stained with H-33342. Image width corresponds to 80 
µm. Data are representative of three independent experiments. Arrows indicate cofilin knock-down cells 













































Figure 5.2.3. Depletion of endogenous cofilin protein inhibits apoptosis. Cells transfected with either 
cofilin or control siRNA were treated with either (A) 1 µM STS or (B) 100 µM etoposide for the indicated 
time points, fixed and stained with H-33342 and cofilin antibody. Apoptosis was scored according to nuclei 
morphology (condensed and fragmented nuclei stained with H-33342) in 300 cofilin knock-down cells and 
data presented are means ± SD values from four independent experiments. 
 
 
Figure 5.2.4. Cofilin silencing confers cellular viability. Cell cultures transfected with either cofilin or 
control siRNA contained approximately 40% cells displaying cofilin knock-down phenotype (determined 
by cofilin immunostaining). Viability in the mixed cultures (containing cofilin knock-down cells and 
cofilin positive cells) treated with STS (1 µM, 6 hours) were assessed by measuring WST-1 reduction 
capacity (A) and clonogenicity (B). Data are means ± SD from three independent experiments. ** indicates 
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viability of cells transiently transfected with cofilin siRNA and exposed to STS. In the 
presence of cofilin siRNA, 40% of the cells were viable, while only 10% of the cells 
survived STS treatment in the presence of control siRNA (fig. 5.2.4.A). As the 
transfection efficiency was approximately 40%, this corresponds to almost complete 
protection for cofilin knock-down cells. Cofilin knock-down cells that survived the 
apoptotic induction by STS displayed long term survival and were subsequently able to 
proliferate and formed 50% more colonies than those cells treated with control siRNA 
(fig 5.2.4.B).  Our data thus indicate that cofilin plays a crucial role in the initiation of 
apoptosis by STS and etoposide. 
 
5.3. Dephosphorylated cofilin localise on mitochondria of apoptotic cells  
Since cofilin oscillates between a phosphorylated and a dephosphorylated form of serine 
3 residue (Arber et al., 1998);(Yang et al., 1998), we separated the two forms of cofilin 
from cytosolic and mitochondrial fractions on 2-D gels and detected these with an anti-
cofilin antibody. Both phosphorylated and dephosphorylated forms of cofilin can be 
found in cytosolic fraction of control cells (fig. 5.3.1.A). Treatment of cytosolic proteins 
with the alkaline phosphatase (AP) resulted in the disappearance of the phosphorylated 
form and an increase of the dephosphorylated form of cofilin.  
 
Consistent with our previous observations, mitochondria isolated from control cells 
contained no cofilin (fig. 5.3.1.B). Upon apoptosis induction with STS for 1 hour, only 
dephosphorylated cofilin was present in the cytosolic as well as mitochondrial fractions 



























Figure 5.3.1 Phosphorylation status of cofilin. (A) Separation of phosphorylated and dephosphorylated 
form of cytocolic cofilin. S100 fractions from untreated SH-SY5Y cells were incubated with calf intestinal 
alkaline phosphatase (AP) to generate dephosphorylated cofilin. (B) After apoptotic stimulation exclusively 
dephosphorylated cofilin is localised at mitochondria. SH-SY5Y cells were treated with 1 µM STS or 100 
µM etoposide for 1 hour. S100 and gradient purified mitochondrial fractions were subjected to 2-D PAGE 









































in the cytosolic fraction. However, only the dephosphorylated form of cofilin appeared in 
the gradient purified mitochondrial fraction (fig. 5.3.1.B). Since dephosphorylation of 
cofilin occurs in response to diverse signals stimulating motility and shape changes 
without triggering apoptosis, we tested whether dephosphorylated cofilin is localised at 
mitochondria during these processes. Differentiated neutrophil-like HL60 cells (Breitman 
et al., 1980) were activated with the protein kinase C activator phorbol 12-myristate 13-
acetate (PMA) leading to dephosphorylation of cofilin (Zhan et al., 2003). As expected, 
both phosphorylated and dephosphorylated cofilin were found in whole cell lysates from 
neutrophil-like HL60 cells, and upon activation with PMA exclusively dephosphorylated 
cofilin was present (fig. 5.3.2.A). Total cofilin protein levels remained unchanged in non-
stimulated and PMA-stimulated neutrophil-like cells (fig. 5.3.2.B). However, 
dephosphorylated cofilin from PMA-stimulated cells was not observed in gradient 
purified mitochondrial fractions (fig. 5.3.2.B), suggesting that dephosphorylated cofilin 













Figure 5.3.2. Exclusively dephosphorylated cofilin is observed in neutrophil-like HL60 upon PMA 
activation. (A) Differentiated neutrophil-like HL60 cells were activated by 200 nM of the phorbol ester 
PMA (phorbol 12-myristate 13-acetate) for 10 minutes leading to dephosphorylation of cofilin (Zhan et al., 
2003). (B) Dephosphorylated cofilin does not accumulate in mitochondria from activated neutrophil-like 
cells. Whole cell lysate and gradient purified mitochondria were subjected to Western blot analysis for 
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5.4. Expression of cofilin S3D mutant reduces endogenous cofilin 
translocation and inhibits STS-induced apoptosis 
We then investigated whether the phosphorylation status of cofilin can influence its 
ability to translocate to the mitochondria and induce apoptosis. Wildtype cofilin was 
amplified from SH-SY5Y cDNA library using primers wt and cof-HA (see Primer list). 
Two cofilin mutants were generated, mimicking either the dephosphorylated or 
phosphorylated forms by changing the serine 3 residue to alanine (S3A) or aspartate acid 
(S3D), respectively (Nagaoka et al., 1996) by site-directed mutagensis, using cofilin wt in 
pXJ vector as template. The former can actively depolymerise F-actin while the latter is 
inactive. These differences in functions were demonstrated in SH-SY5Y cells over 
expressing both mutants. In cofilin S3A overexpression cells, lower F-actin indicated by 
weak phalloidin staining was observed (Fig 5.4.1). In contrast, cells with cofilin S3D 
overexpression did not present any changes in the F-actin staining. These results showed 
that phosphorylation on serine 3 is the key regulator in cofilin actin deploymerising 
property. COS-7 cells overexpressing HA-tagged wild type (wt) or mutant forms of 
cofilin (S3A and S3D) displayed normal morphology and no increase in basal apoptosis 
compared to vector control 24 h after transfection (9.5 ± 3.7 %, 14.5 ± 5.8 %, 13.8 ± 3.7 
% and 4.8 ± 0.8 % for vector control, wild type, S3A and S3D cofilin, respectively). In 
the absence of apoptotic stimuli, both wild type and mutant forms of cofilin were evenly 
distributed in nucleus and cytoplasm without detection of mitochondrial localisation (fig. 
5.4.2). In the presence of STS, wild type cofilin as well as the S3A mutant were localised 




compared to S3A (fig. 5.4.2.). Reduced mitochondrial localisation of cofilin S3D was not 
due to lower expression level as all three HA-tagged cofilin proteins were expressed at a  
comparable level (fig. 5.4.2.B). 
 
Next, we investigated whether overexpression of cofilin S3D could also affect 
translocation of endogenous cofilin using Western blot analysis. Consistent with the 
above observations, wild type cofilin as well as S3A accumulated in gradient purified 
mitochondrial fractions from STS-treated cells, whereas no cofilin S3D was present (fig. 
5.4.3.A, upper panel). 
 
Importantly, overexpression of cofilin S3D reduced mitochondrial accumulation of 
endogenous cofilin in STS-treated cells (fig. 5.4.3.A, middle panel). Therefore, mutant 
cofilin S3D behaves in a dominant negative manner to suppress endogenous cofilin 
translocation to mitochondria. Accordingly, cofilin S3D reduced STS-induced apoptosis 
by 30%, while apoptosis for cofilin wt and cofilin S3A remained unchanged compared to 
that of vector control (fig. 5.4.3.B). Thus, our data indicate that cofilin’s mitochondrial 















Figure 5.4.1. Cofilin S3A and S3D mutants mimicked the dephosphorylated and the phosphorylated 
cofilin in F-actin depolymerisation function. SH-SY5Y cells transfected with 0.4 µg DNA of HA-tagged 
S3A or S3D cofilin and 0.2 µg pEGFP. Cells were fixed after 16 hours and stained with phalloidin for F-


















Figure 5.4.2.  Cofilin S3D acts in a dominant negative manner blocking cofilin translocation. (A) Sub-
cellular localisation of wild type, S3A, and S3D cofilin proteins.  COS-7 cells loaded with MitoTracker 
Red were transfected with 0.4 µg DNA of HA-tagged wild type (wt), S3A, or S3D cofilin for 16 hours. 
Cells were treated with 1 µM STS for 1 hour, fixed and stained for anti-HA antibodies. Fluorescence 
images were collected at similar focal planes by confocal microscopy. Image width corresponds to 40 µm. 
(B) Expression levels of wild type, S3A and S3D cofilin proteins.  Total cell lysate from untreated cells 
was used for Western blot analysis. 
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Figure 5.4.3. (A) Cofilin S3D blocks translocation of endogenous cofilin. Gradient purified mitochondria 
were used for Western blot analysis. Hsp60 was used as a loading control. (B) Cofilin S3D inhibits STS-
induced apoptosis. pEGFP-C3 was co-transfected and apoptosis scored in GFP-positive cells. Data 
presented are means ± SD values from three independent experiments with 300 GFP-positive cells counted. 
*** indicates a p value < 0.001 calculated using the Tukey-Kramer Multiple Comparisons test 
 
 
5.5. Identification of mitochondria-targeting domains on cofilin  
To identify region(s) that are responsible for cofilin mitochondrial localisation, we 
generated C-terminal HA-tagged truncated forms of cofilin by PCR amplification using 
respective primer set (see Primer list) and cloned the inserts into pXJ vector and 
investigated their sub-cellular localisation by immunofluorescent staining using anti-HA 
antibodies. Surprisingly, while other deletion mutants displayed no mitochondrial 
localisation in the absence of STS (fig. 5.5.A), a mutant with deletion of the N-terminal 
first 15 amino acid residues (cofilin15-166) showed predominant mitochondrial localisation 
(fig. 5.5.B). Deletion of an additional 15 amino acid residues at the N-terminus (cofilin30-
166) abolished its mitochondrial localisation, suggesting that amino acid 15-30 is required 
to target cofilin into mitochondria. However, deletion of the C-terminal residue 106-166 
aa (cofilin15-106) abolished mitochondrial localisation (fig. 5.5.), indicating that additional 
regions in the C-terminus are also required for mitochondrial localisation.  Indeed, GFP 
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fusion proteins containing the cofilin 15-30 aa region were not localised to mitochondria 
(data not shown), suggesting that this region is not sufficient to target cofilin to the 
mitochondria. Most importantly, when we fused the C-terminal residue 106-166 aa to the 
proposed mitochondrial targeting region 15-30 aa (cofilin15-30/106-166), mitochondrial 
localisation was restored (fig. 5.5.). 
 
As expected, fusing the 106-166 aa residues to the N-terminal 1-30 aa residues did not 
result in mitochondrial localisation in the absence of apoptotic stimuli but showed 
mitochondria localisation after STS induction (fig. 5.5.). These data indicate that two 
regions of cofilin are required for its mitochondrial localisation: the N-terminal domain 
consisting of 15-30 aa and the C-terminal region (106-166 aa).   
 
5.6. Mitochondrial targeting of cofilin induces apoptosis  
Next, we evaluated whether mitochondrial-localised cofilin mutants are sufficient to 
induce apoptosis. Cells overexpressing exogenous cofilin15-166 or cofilin15-30/106-166 
displayed typical apoptotic changes such as the clustering of mitochondria around the 
nucleus (fig. 5.5.B), cytochrome c release to the cytoplasm (data not shown) and pyknotic 
nuclei with condensed and fragmented chromatin (fig. 5.6.1.). Mitochondrial-localised 
cofilin15-166 as well as cofilin15-30/106-166 triggered apoptosis in 50% of the cells within 16 
hours after transfection, a potency comparable with that induced by the overexpression of 









































Figure 5.5. Mitochondrial-localised cofilin induces apoptosis. (A) Sub-cellular localisation of cofilin 
deletion mutants. COS-7 cells loaded with MitoTracker Red were transfected with DNA of HA-tagged, 
truncated forms of cofilin for 16 hours. Cells were treated with 1 µM STS for 1 hour, fixed and stained with 
anti-HA antibodies. At least 100 transfected cells were scored, indicated by (-) for none, (+) for slight, (++) 
for medium, and (+++) for strong and exclusive mitochondrial localisation. (B) Mitochondrial localisation 
of cofilin15-166, cofilin15-30/106-166, M-cofilin and M-GFP. Fluorescence images were collected at similar focal 
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Apoptosis triggered by mitochondrial-localised cofilin mutants was blocked by caspase 
inhibitors zVAD-fmk and DEVD-fmk as well as by co-expression with Bcl-xL (fig. 
5.6.1.). In an alternative approach we targeted full-length cofilin expression to the outer 
mitochondrial membrane by fusing HA-tagged cofilin with the mitochondria-targeting 
sequence of Bcl-2 (M-cofilin). As expected, M-cofilin co-localised with the 
mitochondrial marker Mitotracker Red (fig. 5.5.1.B). M-cofilin induced disruption of the 
mitochondrial membrane characterised by cytochrome c release to the cytoplasm (fig. 
5.6.2.) and triggered massive apoptosis (fig. 5.6.1.). Mitochondrial disruption preceded 
apoptotic nuclear changes as we could observe diffuse cytochrome c staining pattern in 









Figure 5.6.1. Cofilin15-166, cofilin15-30/106-166 and M-cofilin trigger caspase-dependent apoptosis. SH-
SY5Y cells pre-incubated with 50 µM of zVAD-fmk or DEVD-fmk were co-transfected with pEGFP-C3 
and the following DNA constructs (cofilin15-166, cofilin15-30/106-166, M-cofilin, Bax, and Bcl-xL) or were 
transfected with the DNA construct M-GFP for 16 hours and stained with H-33342. Nuclei with 
fragmented chromatin were scored in GFP-positive cells. Data presented are means ± SD values from three 





























Accordingly, M-cofilin-triggered apoptosis was also fully blocked by caspase inhibitors 
and partially prevented by co-expression with Bcl-xL (fig. 5.6.1.). As control, 
overexpression of GFP targeted to mitochondria (M-GFP) neither result in morphological 
changes of mitochondria (fig. 5.5.B) nor in apoptosis (fig. 5.6.1.). These data indicate that 
cofilin becomes a potent inducer of caspase-dependent apoptosis once it is targeted to 
mitochondria.  
 
Since overexpression of pro-apoptotic cofilin mutants induced cytochrome c release in 
intact cells (fig. 5.6.2.), we ask if targeting cofilin to mitochondria has a direct influence 
on cytochrome c release on isolated mitochondria. While the pro-apoptotic protein tBid 
efficiently released cytochrome c from isolated mitochondria (Desagher et al., 1999), 
neither cofilin wt nor cofilin15-166 (up to 3.5 µg protein used) induced mitochondrial efflux 
of cytochrome c (fig. 5.6.3.A). The inability of cofilin15-166 to trigger cytochrome c 
release in isolated mitochondria was not a result of slow uptake kinetics, as the extension 
of the incubation time up to 60 min did not lead to detectable cytochrome c release from 
isolated mitochondria. M-cofilin and cofilin15-30/106-166 were not evaluated in this assay, as 
we were unable to generate recombinant proteins because of their potent effect in 
retarding bacterial growth.  Therefore, cofilin alone did not appear to be sufficient to 








Figure 5.6.2. M-cofilin triggers 
cytochrome c release. SH-SY5Y cells were 
transfected with the HA-tagged DNA 
construct M-cofilin and with the DNA 
construct M-GFP for 16 hours and stained 
simultaneously for cytochrome c and/or HA. 
Nuclei were stained with H-33342. Image 




















Figure 5.6.3. Recombinant Cofilin15-166 does not induce cytochrome c release from isolated 
mitochondria. (A) Mitochondria (15 µg, 0.5 mg/ml) were incubated for 30 minutes with different 
concentrations of the recombinant proteins GST, tBid, cofilin wt and cofilin15-166 or with control buffer 
(PBS). Proteins from supernatant (upper panel) and mitochondrial pellets (lower panel) were separated by 
SDS–PAGE and the cytochrome c content was analysed by Western blotting. Recombinant tBid (0.5µg) 
was used as positive and GST (1 µg) as negative control. Equal loading of mitochondrial pellets was 
controlled by VDAC. (B) Recombinant protein fractions of GST, tBid, cofilin wt and cofilin15-166 were 
separated by SDS-PAGE. The Coomassie blue bands corresponding to the recombinant proteins used in the 



















































































































5.7. A functional actin-binding domain is required for cofilin-induced 
apoptosis but not mitochondrial localisation  
To access the role of the actin-binding domain located at the C-terminal region of cofilin 
in affecting mitochondrial localisation and apoptosis, we generated cofilin mutants by 
substituting one or both lysine residues (K112 and K114) with glutamine (Q) on the 
mitochondrial-localised cofilin mutant cofilin15-166 [KQ1 (K112Q), KQ2 (K114Q) and 
KQ3 (K112, 114Q) fig. 5.7.1.A] using site-directed mutagensis.  Substitution of both 
lysine with glutamine results in complete loss of F-actin binding and depolymerising 
activity of cofilin, while single amino acid substitution (K112Q or K114Q) partially 
reduces these activities (Moriyama et al., 1992).  Similar to cofilin15-166, the cofilin KQ 
mutants with either single or double substitution displayed mitochondrial localisation 
(fig. 5.7.1.A and B) indicating that a functional actin-binding domain is not required for 
cofilin translocation to mitochondria.  
 
Surprisingly, while the cofilin KQ1 mutant showed reduced apoptosis-inducing activity, 
cofilin KQ3 with both lysine substitutions showed complete loss of apoptosis-inducing 
activity (fig. 5.7.2.). Interestingly, overexpression of KQ3 mutant behaves as a dominant 
negative form to inhibit STS-induced apoptosis (78% ± 3.7 and 38% ± 7.1 for wild type 
and KQ3 respectively, fig 5.7.3.). These data suggest that a functional actin-binding 






































Figure 5.7.1.  Mitochondrial localisation of cofilin is independent of its actin-binding activity. (A) 
Sub-cellular localisation of cofilin KQ mutants.  COS-7 cells loaded with MitoTracker Red were 
transfected with HA-tagged KQ mutants, KQ1, KQ2 and KQ3 for 16 hours. Cells were fixed and stained 
with anti-HA antibody and H-33342. At least 100 transfected cells were scored for the cofilin mutants’ sub-
cellular localisation. (B) Mitochondrial localisation is independent of functional actin-binding domain.  
Fluorescence images were collected at similar focal planes by confocal microscopy. Image width 















































Figure 5.7.2. Mitochondrial-localised cofilin mutant-induced apoptosis is dependent of the actin-
binding domain. SH-SY5Y cells were co-transfected with KQ mutant constructs and pEGFP-C3 for 16 
hours and stained with H-33342. Apoptosis was scored in GFP-positive cells and data presented are means 
± SD values from four independent experiments with 200 GFP-positive cells counted. 20 µg total cell 





Figure 5.7.3. Cofilin KQ3 inhibits STS-induced 
apoptosis. SH-SY5Y cells co-transfected with 
pEGFP-C3 and either construct cofilin KQ3 
mutant, or cofilin wt, or vector control, were 
treated with 1 µM STS. Apoptosis was scored 
according to the nuclei morphology in GFP-
positive cells. Data presented are means ± SD 
values from three independent experiments with 
300 GFP-positive cells counted. *** indicate a p 
value < 0.001 calculated using the Tukey-Kramer 













































In an attempt to search for trafficking proteins involved in the transduction of death 
signal in or out of mitochondria during the early phase of apoptosis, we utilised 
comparative proteomics of mitochondrial proteins from healthy and apoptotic cells. We 
demonstrated cytoplasmic cofilin translocated to the mitochondria as early as five 
minutes after death induction. In addition to the observation of mitochondrial-localised 
cofilin at the early phase of STS induced apoptosis, we also illustrated with cofilin15-166 
and M-cofilin, that mitochondrial localisation of cofilin is necessary and sufficient to 
induce cytochrome c release and massive apoptosis in intact cells. Translocation of 
cofilin to mitochondria was crucial for the initiation of apoptosis as blocking its 
translocation by phosphorylation mutant, or knocking-down of its protein level, led to the 
inhibition of apoptosis.   
 
In this study, cofilin targeting to the organelle was an essential step for engaging the pro-
apoptotic effect of cofilin. This is further demonstrated in the activation of cells with 
PMA that mimics signaling during chemotaxis in neutrophil-like cells. Cofilin undergoes 
dephosphorylation, which is consistent with its role in binding, and reorganising actin 
cytoskeletal network in response to chemotaxis. Interestingly, although 
dephosphorylation event is similar to that observed in STS or etoposide induced 
apoptosis, we did not observe translocation of the dephosphorylated cofilin to 
mitochondria. The difference in localisation suggests that mitochondrial translocation of 




understand the role of cofilin in apoptotic pathway, we characterised the ability of cofilin 
to translocate during the early phase of apoptosis.  
 
Proposed intra-molecular regulation of mitochondrial-translocating 
cofilin 
Mitochondrial translocation of cofilin was achieved by three primary determinants on 
cofilin: (i) the exposure of N-terminal sequences (15-30 aa), (ii) the C-terminal region 
and (iii) the dephosphorylation of cofilin at serine 3. 
 
Exposure of N-terminal sequences (15-30 aa) 
The sequential deletion studies on the cofilin protein reveal a 15 amino acid stretch (15-
30 aa) of novel mitochondrial-targeting signal at the N-terminal, which is required for 
cofilin mitochondrial translocation. The nuclear magnetic resonance structure of the other 
ADF family member, destrin that shared approximately 90% sequence identity (diagram 
6) with cofilin (Hatanaka et al., 1996) suggest that the first nine amino acids at the N-
terminal of both proteins may form an unstructured flexible loop, which could mask the 
adjacent sequences (15-30 aa) in the absence of apoptotic stimuli. Diagram 7 shows the 
Rasmol model of human destrin. Upon apoptosis induction or by deletion of this 
inhibitory region, e.g. in case of deletion mutant cofilin15-166, this mitochondrial 
localisation signal can be unmasked to allow cofilin translocation to mitochondria.  
Although the N-terminal 15-30 aa is required for cofilin to undergo mitochondrial 




the GFP to the mitochondria, suggesting that other domains of the protein are also 
required for cofilin translocation.  
 
C-terminal region 
In addition to the 15-30 aa, the C-terminal half of the cofilin (106-166 aa) is also required 
for mitochondrial localisation of cofilin. However, the translocation to the mitochondria 
did not require a functional actin-binding domain. Point mutation of the KQ3 mutant 
(Lys112, 114 glutamine) with abolished actin-binding capability had no effect on the 
mitochondrial translocation of the cofilin15-166. Structural analysis using circular 
dichroism of cofilin showed close proximity of the N-terminal of the protein and the C-
terminal actin-binding domain (Pope et al., 2000). It is possible that in the absence of 
apoptotic stimuli, the N-terminal first 15 aa flexible loop interacts with the C-terminal 
structure, resulting in a closed structure formation, which would masked the 
mitochondrial-targeting signal at the N-terminal.  
 
Dephosphorylation of cofilin at serine 3 
The last determinant of cofilin undergoing mitochondrial translocation is based on the 
findings that exclusively dephosphorylated cofilin accumulated in mitochondria upon 
apoptosis induction. Concomitantly, mutant mimicking the phosphorylated cofilin at 
serine 3 (cofilin S3D) could suppress mitochondrial translocation. As shown in the yeast 
cofilin systematic mutagensis and three-dimensional structural analysis, the first 5 
residues at the N-terminal end of the protein that includes the human equivalent of serine 




and 114 on the C-terminal actin-binding domain (Lappalainen et al., 1997). Pope et al., 
has shown that serine 3 in close proximity with lys 112 and 114 (Pope et al., 2000). This 
is consistent with our hypothesis that interaction of the C-terminal helix with the 
phosphorylated serine 3 at the N-terminal flexible loop may mask the adjacent amino 
acid sequences (15-30 aa), resulting in hidden mitochondrial-targeting signal. The 
dephosphorylation of serine 3 during the induction of apoptosis probably result in the 
releasing of the intra-molecular inhibition and exposing the mitochondrial-targeting 
signal such that cofilin translocates to mitochondria where it can exert its death effect. 
Such proposed intra-molecular regulation for cofilin is not uncommon.  
 
Interestingly, Bax, the potent pro-apoptotic protein, was proposed to be regulated in a 
similar manner (Goping et al., 1998). From the deletion studies, Goping has shown that in 
the control cells, the mitochondrial-targeting signal at the C-terminal of Bax protein is 
hidden as the N-terminal first 20 aa interacts with the C-terminal of the protein. This 
“closed” structure is opened in the event of apoptosis, probably through 
dephosphorylation of serine 184 (Nechushtan et al., 1999), expose the mitochondrial- 
targeting signal and allowing Bax translocation to mitochondria where it causes 
cytochrome c release and apoptosis. 
 
The hypothesis of cofilin mitochondrial translocation being regulated intra-molecularly 
awaits further experiments with structural and mutational studies on the N and C-terminal 










Diagram 6: Protein alignment of human destrin and cofilin.  Both proteins shared ~90% sequence identity. 
 
 
Diagram 7: Rasmol model of human destrin 1AK6 (NMR) (Hatanaka et al., 1996). The first nine amino 
acid form an unstructured loop with serine 3 in close proximity with the actin-binding domain. The 
proposed mitochondrial localisation signal (15-30 aa) is “clamped” between the nuclear-localisation signal 





Ser 3, in close 
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Apart from translocating to the mitochondria to induce apoptosis, cofilin’s actin-binding 
capability also plays an important role in its apoptotic ability at the mitochondria. Cofilin 
has been well established for its role in actin cytoskeleton reorganisation. Its function is 
negatively regulated by the phosphorylation of the third serine residue by LIM kinase that 
is regulated by the Rho family of GTPases (refer to diagram 5 for the signalling 
pathway). The actin depolymerisation activity is also inhibited by phosphatidyl inositol 
4,5-bisphosphate (PIP2) interaction. Intriguingly, substitution of two lysine residues on 
the actin-binding domain of cofilin, which abolished F-actin-binding, prevents its 
apoptosis-inducing activity. Biochemical data demonstrated that lysine 112 and lysine 
114 of cofilin are differentially involved in binding to PIP2 and actin respectively 
(Moriyama et al., 1992). Therefore, both PIP2 and actin could play a role in cofilin-
induced apoptosis. However, substitution of both lysine 112 and 114 (KQ3) resulted in 
only 50% reduction of the cofilin-PIP2 interaction but complete loss of cofilin-actin 
interaction. Therefore, we suggest that the actin-binding activity of cofilin is crucial for 
its apoptosis-inducing activity.  
 
As a actin depolymerising factor, cofilin dephosphorylation and activation occurs in 
response to many stimuli that activate cells in processes requiring changes in actin 
organisation e.g. during chemotaxis (Bamburg, 1999). Cofilin dephosphorylation can be 
achieved by phosphatases such as slingshot and PP2A (Ambach et al., 2000; Niwa et al., 
2002). We found that approximately 60% of total cellular cofilin was dephosphorylated 
in the cytosolic fraction of control cells. Upon cell stimulation with STS, exclusively 




induction with etoposide, both phosphorylated and dephosphorylated cofilin were 
detectable in the cytosolic fractions. Detection of exclusively dephosphorylated cofilin in 
the cytosolic fractions after apoptosis induction with STS is likely due to STS’s action as 
a general kinase inhibitor. Therefore, in contrast to actin reorganisation, the activation of 
cofilin specific phosphatases during the induction of apoptosis may not be required for 
cofilin’s translocation to mitochondria. 
 
In addition to interaction with kinases and phosphatases, pro-apoptotic proteins can be 
tightly regulated either by compartmentation or physically inhibited by other proteins or 
both. The well studied Bad is a good example of such regulation. In the healthy control 
cells, Bad is phosphorylated and sequestered to 14-3-3 protein, preventing it from 
interacting with the Bcl-2 anti-apoptotic family member on the surface of mitochondria. 
Dephosphorylation in the event of death signal, results in dissociation of this inhibition 
complex and subsequent translocation of the protein to the mitochondria where it 
interferes with mitochondrial integrity resulting in cytochrome c release (Zha et al., 
1996). 
 
Similarly, cofilin interaction with other proteins in the cytosol or during translocation 
may play a key role in its death-inducing capability at the early phase of apoptosis. It has 
been shown that 14-3-3ζ can bind to both phosphorylated and dephosphorylated cofilin, 
with higher affinity for phosphorylated cofilin (Gohla and Bokoch, 2002). Intriguingly, a 




identified putative mitochondrial localisation signal (15-30 aa). Therefore, 14-3-3ζ could 
sequester cofilin in the cytoplasm and thereby suppress its mitochondrial localisation.  
 
Although we have shown that cofilin translocation to mitochondria is necessary to induce 
apoptosis, the question remains of how does this induces cytochrome c release and cell 
death in intact cells?  
 
Bcl-2 family like function of mitochondrial cofilin 
The Bcl-2 pro-apoptotic family members form the central dogma by their active 
trafficking to the organelle in the early stages of apoptosis. Direct signaling to the 
mitochondria via translocation is however, not restricted to Bcl-2 family members. 
Recent reports on several other proteins such as the transcription factor TR3 (Li et al., 
2000), the Peutz-Jegher gene product LKB1 (Karuman et al., 2001) and P53, a cell cycle 
check point protein (Mihara et al., 2003) have been shown to translocate into the 
mitochondria, thereby inducing apoptosis.  
 
Cofilin mitochondrial translocation may adopt a similar role as the pro-apoptotic Bcl-2 
proteins and p53 protein. Both groups of proteins upon translocation in the early phase of 
cell death interact with the anti-apoptotic Bcl-2 or Bcl-xL on the mitochondrial surface 
allowing the Bax-like pro-apoptotic molecules to exert their death effect. To test this 
hypothesis, one can use cross-linking experiments to pull out cofilin interacting molecule 




partner of cofilin. These will allow us to gain an insight if cofilin interacts with the Bcl-2 
family protein on the mitochondrial surface.  
 
Actin-depolymerising function of mitochondrial cofilin  
The mechanism by which cofilin’s actin-binding ability induces apoptosis is not clear. As 
dephosphorylated cofilin binds to actin and translocates into mitochondria, actin 
cytoskeletal changes during apoptosis may affect mitochondrial function. Many models 
have been speculated on what induces the loss of mitochondrial membrane potential and 
release of apoptogenic factors, which are some of the hallmarks for apoptosis (Lawen, 
2003).  Mitochondrial dysfunction is one of the proposed models for the event. There is 
by far no direct correlation between the actin cytoskeletal network and the integrity of the 
organelle. The identification of cofilin and the importance of its actin- binding residue in 
apoptosis when localised on the mitochondria, suggest that the actin depolymerising 
factor may play an important role in reorganisation of the actin network around the 
organelle, causing the dysfunction of mitochondria and subsequent release of 
apoptogenic factors. This model is concomitant with the overexpression of 
mitochondrial-localised cofilin KQ3 mutant which maintains the ability to translocate to 
mitochondria but lost its death inducing function when the actin-binding ability is 
abolished in the mutant.  
 
Interaction with other proteins 
Another way that cofilin initate apoptosis on the mitochondria is dependent on its 
interacting protein. We had established the need for cofilin to localise to the mitochondria 




However, the recombinant pro-apoptotic mutant of cofilin (cofilin15-166) was ineffective 
to trigger the efflux of cytochrome c from isolated mitochondria. This suggests that 
additional modification events and/or cofactors are necessary during apoptosis for cofilin 
induced cytochrome c release. 
 
Another line of support for the requirement of the yet unknown interacting protein(s) of 
cofilin comes from the studies using the constitutively phosphorylated cofilin mutant 
(S3D). Cofilin S3D protein do not translocate to mitochondria in the presence of STS. In 
addition, it inhibits the movement of the endogenous cofilin, suggesting that the S3D 
protein interacts with the co-factor(s) that is required for cofilin mitochondria 
translocation cell death. It would be interesting to note if the co-factor(s) required for 
translocation and cell death is part of the Bcl-2 family or known pro-apoptotic proteins 
that also display mitochondrial translocation during the early phase of apoptosis. The set 
up of a permanent cofilin knock-down line would be informative to investigate the pro-
apoptotic proteins’ profile in STS and etoposide induced cell death in the constant 
absence of cofilin.   
 
Novel death-inducing function of mitochondrial cofilin 
Cofilin-inducing apoptosis on the mitochondria may arise due to its novel function other 
than actin depolymerisation. Proteins with dual roles in the mammalian system are 
common. Cytochrome c, which functions in the oxidative phosphorylative pathway in 
mitochondria, also participates in the activation of caspase-9 at the apoptosome (Liu et 




resides in the mitochondria upon release into the cytosol, relieves caspases of IAP 
inhibition, enhancing apoptosis. However in physiological condition, it is likely that Omi, 
a chaperone like protein, plays an important role in sustaining mitochondrial stability via 
the maintenance of proper folding of mitochondrial protein (Jones et al., 2003). 
Therefore, it is not surprising if the mitochondrial cofilin adopts a different function upon 
translocating to mitochondria, inducing cytochrome c release, and apoptosis. 
 
Although the role of cofilin in apoptosis is only established recently, there are already 
several studies that demonstrated the involvement of the cofilin’s upstream signaling 
protein in the event of cell death. Gene deletion of LIM kinase 2 which is the only known 
kinase that phosphorylate cofilin, displayed enhanced susceptibility to apoptosis in the 
spermatocytes of the knockout mice (Takahashi et al., 2002). Furthermore, 
overexpression of PAK1 and PAK4, which activate LIM kinases and thereby lead to the 
phosphorylation of cofilin, were shown to promote cell survival (Schurmann et al., 2000). 
On the other hand, Rho inactivation which leads to inhibition of LIM kinases resulted in 
apoptosis (Bobak et al., 1997). Since cofilin is downstream of LIM kinase, PAK and Rho 
(refer to diagram 4), the data indicate that phosphorylation of cofilin is prosurvival, 
concomitantly with our findings that dephosphorylated cofilin at the mitochondria 
induces cell death. The importance of cofilin phosphorylation status is also demonstrated 
in the previous findings that neurodegenerative stimuli via dephosphorylated cofilin led 







Conclusions and future perspective 
In the process of screening for proteins translocating in and out of mitochondria, we 
identified cofilin, an actin binding and depolymerising factor. Cofilin is inactivated by the 
upstream Rho GTPases via phosphorylation by LIM kinase as well as via the binding of 
PIP2. Cofilin dephosphorylation or activation is observed in the event that requires actin 
reorganisation such as chemotaxis. Our studies identified a novel role of 
dephosphorylated cofilin. At the early stage of death signal transduction, the protein 
undergoes dephosphorylation which may result in its disengagement with 14-3-3ζ 
proteins and exposure of the mitochondrial localisation signal at 15-30 aa. This change 
may result in translocation of the protein to the mitochondrial outer membrane where it 
exerts its potent death effect. How cofilin translocates to the mitochondria as we 
proposed, would require further structural studies. 
 
Mitochondrial translocation of the cofilin is independent of its actin-binding domain, 
however, cofilin can only induce cytochrome c release from the mitochondria in the 
presence of functional actin-binding domain. Detailed mechanisms of how the 
cytoskeletal protein-induced cell death awaits further analysis. Based on the data, we 
speculate that cofilin either acts in a cytoskeletal independent manner, interacting with 
anti-apoptotic proteins and thus inducing mitochondrial release of cytochrome c, or it 
exerts its actin-depolymerising function reorganising the actin cytoskeleal network 
around the organelle causing dysfunction, subsequently resulting in the release of 
cytochrome c. Since cytochrome c and p53 adopt dual roles in the complex mammalian 




mitochondria induces cytochrome c release and apoptosis by gaining a novel function 
regardless of its actin depolyermising ability. How the actin depolymerising factor 
induces apoptosis when it localised on the mitochondria would definitely provide new 
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